US8192394B2 - Method and system for manual and autonomous control of an infusion pump - Google Patents

Method and system for manual and autonomous control of an infusion pump Download PDF

Info

Publication number
US8192394B2
US8192394B2 US11/557,926 US55792606A US8192394B2 US 8192394 B2 US8192394 B2 US 8192394B2 US 55792606 A US55792606 A US 55792606A US 8192394 B2 US8192394 B2 US 8192394B2
Authority
US
United States
Prior art keywords
alerts
infusion pump
disruptive
time
pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US11/557,926
Other versions
US20070124002A1 (en
Inventor
Mark C. Estes
Mitchell Wenger
Morten Mernoe
James Causey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insulet Corp
Original Assignee
Asante Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37835238&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US8192394(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US11/557,926 priority Critical patent/US8192394B2/en
Application filed by Asante Solutions Inc filed Critical Asante Solutions Inc
Assigned to M2 MEDICAL A/S reassignment M2 MEDICAL A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CAUSEY, JAMES, WENGER, MITCHELL, ESTES, MARK C., MERNOE, MORTEN
Publication of US20070124002A1 publication Critical patent/US20070124002A1/en
Assigned to M2 MEDICAL GROUP HOLDINGS, INC. reassignment M2 MEDICAL GROUP HOLDINGS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: M2 MEDICAL A/S
Assigned to M2 GROUP HOLDINGS, INC. reassignment M2 GROUP HOLDINGS, INC. CORRECTIVE DOCUMENT ORIGINAL DOCUMENT WAS RECORDED AT REEL 022440, FRAME 0904. Assignors: M2 MEDICAL A/S
Assigned to ASANTE SOLUTIONS, INC. reassignment ASANTE SOLUTIONS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: M2 GROUP HOLDINGS, INC.
Priority to US13/468,669 priority patent/US20120220940A1/en
Publication of US8192394B2 publication Critical patent/US8192394B2/en
Application granted granted Critical
Priority to US13/489,603 priority patent/US9205192B2/en
Priority to US13/490,602 priority patent/US9114209B2/en
Priority to US13/491,828 priority patent/US20120245524A1/en
Assigned to BIGFOOT BIOMEDICAL, INC. reassignment BIGFOOT BIOMEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASANTE LLC
Assigned to ASANTE LLC reassignment ASANTE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASANTE SOLUTIONS, INC.
Assigned to MADRYN HEALTH PARTNERS, LP reassignment MADRYN HEALTH PARTNERS, LP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIGFOOT BIOMEDICAL, INC.
Assigned to MADRYN FUND ADMINISTRATION, LLC reassignment MADRYN FUND ADMINISTRATION, LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MADRYN HEALTH PARTNERS, LP
Assigned to BIGFOOT BIOMEDICAL, INC. reassignment BIGFOOT BIOMEDICAL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MADRYN FUND ADMINISTRATION, LLC
Assigned to INSULET CORPORATION reassignment INSULET CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIGFOOT BIOMEDICAL, INC.
Assigned to MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT reassignment MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT SECURITY AGREEMENT SUPPLEMENT Assignors: INSULET CORPORATION
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M2005/14268Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with a reusable and a disposable component
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M2005/31518Piston or piston-rod constructions, e.g. connection of piston with piston-rod designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3561Range local, e.g. within room or hospital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14566Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • the present invention relates to autonomous and manual control of an infusion pump.
  • An infusion pump is used to infuse fluids, medication or nutrients into a patient's circulatory system. It is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used.
  • Infusion pumps can administer fluids in ways that would be impractically expensive or unreliable if performed manually.
  • infusion pumps can administer 1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to the maximum number per hour allowed (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.
  • the pumps can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system—a very popular local spinal anesthesia for childbirth).
  • a method and system is provided for both autonomous and manual control of an infusion pump for delivering medication to a patient.
  • the manual control may provided by an onboard assistance device allowing the user to make entries and corrections.
  • a method for directly transferring operating parameters from one infusion pump device to a second infusion pump device includes providing a first infusion pump device including parameters to be transferred, establishing a communications link from the first infusion pump device to a second infusion pump device, and transferring the parameters from the first infusion pump device to the second infusion pump device.
  • the communication link may be established using wired means, by contact between the first infusion pump device and the second infusion pump device, or by using wireless means.
  • the parameters may include historical treatment information, may include user information, or may include operating parameters.
  • a method of entering food information into an infusion pump system includes providing a foodstuff identification, and using device assisted data entry to enter the foodstuff identification into an infusion pump system.
  • the method may also include using the entered foodstuff identification to retrieve foodstuff composition information.
  • the foodstuff identification may include a barcode, or may include an RFID tag.
  • the foodstuff identification may be entered using a scanner in an infusion pump system, or may be entered using an RFID reader in an infusion pump system.
  • An infusion pump system includes an infusion pump body, a control system, and an RFID reader, wherein the RFID reader is in communication with the control system.
  • the RFID reader may be contained within the infusion pump body, or form part of the infusion pump body.
  • a method for temporarily disabling a disruptive alert of an infusion pump system includes receiving a request to disable disruptive alerts from an infusion pump system for a specified period of time, disabling disruptive alerts from the infusion pump system for the specified period of time, and re-enabling disruptive alerts after the specified period of time has passed.
  • Health alerts may remain active during the specified period of time.
  • the specified period of time may be determined by the difference between the current time and a requested time, or the specified time may be determined by a request for a specified time period.
  • a method of determining a treatment amount for an infusion pump system includes obtaining treatment information including foodstuff composition information, food on board information, and insulin on board information, and determining a recommended bolus amount based on the treatment information.
  • the foodstuff composition information may include a carbohydrate ratio, may include quantity information, or may include carbohydrate, fat, and protein information.
  • the method may also include using user metabolism information in calculating a bolus amount.
  • user metabolism information may include insulin sensitivity information, or glucose sensitivity information.
  • a method of determining a treatment amount for an infusion pump system includes obtaining foodstuff composition information including carbohydrate, fat, and protein composition information of a foodstuff; and determining a recommended bolus amount based on the foodstuff composition information.
  • Determining a recommended bolus amount may also be based on user metabolism information, or may also be based on a user's food on board and insulin on board information.
  • the foodstuff composition information may be entered into the infusion pump system using device assisted data entry.
  • FIG. 1 is an illustration of an exemplary infusion pump system.
  • FIG. 2 is an illustration of a cross sectional view of the exemplary infusion pump system of FIG. 1 .
  • FIG. 3 is an illustration of transferring data between two infusion pump systems.
  • FIG. 4 is a flow chart illustrating a method of assisted modification of infusion pump parameters.
  • FIG. 5 is a flow chart illustrating a method of providing external input to modify infusion pump parameters.
  • FIG. 6 is a flow chart illustrating a method of analyzing received criteria to determine or enhance a bolus amount in an infusion pump system.
  • FIG. 7 is a flow chart illustrating a method of postponing alert messages in an infusion pump system.
  • FIG. 8 is a flow chart illustrating a method of postponing medication dispersion in an infusion pump system.
  • FIG. 9 is a flow chart illustrating a method of transferring infusion pump parameters to one or more devices.
  • FIG. 10 is a flow chart illustrating a method for entering food data into an infusion pump to receive a treatment recommendation.
  • FIG. 11 is a block diagram illustrating an exemplary architecture for operating and controlling an infusion pump system.
  • FIG. 12 is a schematic diagram of an example of a generic infusion pump computing system.
  • the system may receive input, analyze input, display some or all analysis data to an infusion pump user, and may perform modifications to one or more infusion pump parameters.
  • the infusion pump system may automatically prompt the user to perform a system task or modification. For example, when a blood glucose (“BG”) reading is dangerously high in the pump user, the system may prompt the user with information regarding decisions on dispensing medication or nutrients into the pump user's circulatory system, such as insulin medication to lower the BG level in the user. The user can then perform various tasks, including, but not limited to, ignoring the prompt, implementing the suggested protocol, or modifying the suggested protocol before implementing the modified protocol. In one embodiment, upon receiving a user requested modification, the system may present and display information to the user indicating that the infusion pump parameters should remain unchanged.
  • BG blood glucose
  • the methods described in this application can be performed manually based on a request from a pump user, automatically based on previously entered user data (e.g., an alarm or criteria set by the user), or a combination of both.
  • the manual control may be provided by an onboard assistance system to allow the pump user to make entries and corrections in the system.
  • FIG. 1 is an illustration of an exemplary infusion pump system 100 that may be used to perform the methods described in this disclosure.
  • the infusion pump system 100 includes a pump body 102 , an infusion site interface 104 , and a reservoir 105 .
  • the pump body 102 includes an upper housing 106 and a lower housing 108 which define a periphery in which the mechanisms of a pump unit reside.
  • the upper and lower housings 106 , 108 may include openings or penetrations for attachment and guidance of the infusion site interface 104 to the pump body 102 .
  • openings in the pump body may allow for the installation of the reservoir 105 contained within the pump body 102 , and maintenance of the reservoir 105 that may be in communication with the infusion site interface 104 for dispensing medication.
  • the infusion site interface 104 may provide for continuous or intermittent subcutaneous fluid infusion.
  • One or more buttons 110 may be used to enter user requests into the pump system.
  • FIG. 2 is an illustration of a cross sectional view of the exemplary infusion pump system of FIG. 1 .
  • a mechanism is contained in the pump body 102 that comprises the reservoir 105 , a drive mechanism 202 and a control system (not shown).
  • the reservoir 105 is comprised of a distal end 204 and a proximal end 206 , and is cylindrical in geometry with the distal end 204 sealed by a moveable plunger 208 of matching geometry as the reservoir 105 and the proximal end 206 are contained by a pump body septum 210 .
  • the infusion pump system 100 generally dispenses fluid when the drive mechanism 202 is actuated, thereby applying pressure internal to the reservoir, such that a substance contained within the reservoir may be driven through a device (not shown) that may pierce the pump body septum 210 .
  • the actuation of the drive mechanism 202 may be governed by the control mechanism.
  • the geometry of the reservoir 105 has been shown as cylindrical for illustrative purposes only and as such, the reservoir 105 is geometry independent.
  • the system may also include communication circuitry and functionality to upload, download or otherwise transfer data to and from the pump system.
  • the infusion pump system 100 may transfer, upload, or download data to a computer, a data repository, to itself, or to another infusion pump, to name a few examples.
  • the infusion pump system 100 may include circuitry designed for sending and receiving data, such as communication chipsets including, but not limited to, universal serial bus (USB), RS-232, Ethernet, Bluetooth, radio frequency, infrared, wireless Ethernet, or other such technologies.
  • the system 100 may include an infrared port 212 , a USB port 214 , and a radio frequency identification (RFID) reader 216 .
  • RFID radio frequency identification
  • the infusion pump system may include circuitry for connecting an external RFID reader.
  • some, all, or none of the above communication chipsets, connectors, or technologies may be included in the system, and as such, other ports and connector technologies are possible.
  • additional communication ports may be available for connecting peripheral data collection devices.
  • the data collection devices may be used to enter input into the infusion pump system.
  • the data collection devices may include, but are not limited to, a bar code scanner, a radio frequency (RF) reader, an optical scanner, an infrared scanner, or other wired or wireless data collection device.
  • the data collection device may allow data to be uploaded or entered into the pump system by selecting or scanning food and medication information, for example.
  • the pump user may download data from a website, or other means where wired or wireless communication is available (e.g., a mobile telephone, or a personal digital assistant (PDA)).
  • PDA personal digital assistant
  • the pump user may collect data for the infusion pump system in various ways. Device assisted data entry may be utilized to obtain additional information beyond that which may be easily entered using a manual approach.
  • a pump user may user the USB port 214 to plug in a barcode scanner, and can scan foodstuffs to obtain additional information, such as carbohydrate, fat, and protein amounts, mass, brand, food group, or other foodstuff identifying features.
  • the infusion pump system may include an on-board barcode scanner. Using a barcode scanner, the user may scan the foodstuff item and enter one or more identifying features in the user interface.
  • the pump user may use an onboard RFID reader 216 to scan RFID tags located on foodstuffs, rather than a barcode reader.
  • a RFID reader may be plugged in a USB port or other input/output port.
  • other device assisted data-entry approaches may be used.
  • wireless device assisted data entry implementations may be used (e.g., a wireless RFID reader or wireless barcode scanner may be used to communicate foodstuff information to the infusion pump system).
  • the foodstuff information may include a product identifier or code.
  • the product identifier or code may be used to obtain additional product information from an onboard data repository.
  • a UPC code may be used to identify a foodstuff, which is then looked up in a data repository to obtain nutrition and other information regarding the foodstuff.
  • Collecting data in the infusion pump system may be advantageous when calculating treatment methods for pump users.
  • data collection devices may also provide a method for entering food identification and composition information.
  • the composition information may comprise a carbohydrate ratio, quantity information, carbohydrate content, fat content, or protein content.
  • the collected data may be used to determine and recommend a particular bolus amount.
  • FIG. 3 is an exemplary illustration of transferring data between two infusion pump systems.
  • a first pump 302 and a second pump 304 may establish pump-to-pump communications to transfer data between the pumps.
  • one or more communication ports on the pumps may initiate the communication.
  • an infrared port on the first pump 302 may initiate communication with an infrared port on the second pump 304 upon coming into close proximity.
  • the communication may be a wired communication where a pump user has “connected” the pumps together (e.g., as in a USB to USB cable connection). Regardless of which pump initiated the connection, a portion of data may be bi-directionally transferred between both pumps, as facilitated by a pump user. In some implementations, no data may be transferred (e.g., when a pump user has not requested a transfer).
  • the transferring of data may commence.
  • the processing devices on each pump may invoke their respective data repositories to begin transferring data between the pumps.
  • operating parameters, historical treatment data, user information, configuration data, pump user data, pump manufacturer data, medication on board, and other system information may be transferred from one pump to another pump.
  • FIG. 4 is a flow chart illustrating a method 400 of assisted modification of infusion pump parameters.
  • the method 400 will be described in reference to an infusion pump system that processes user requests and infuses fluids, medication, nutrients or other materials into the body of the pump user.
  • the user requests may include various modifications to system operating parameters, such as modifications to bolus profile, basal rate, RTC, BG history, delivery history, bolus history, and others.
  • system operating parameters such as modifications to bolus profile, basal rate, RTC, BG history, delivery history, bolus history, and others.
  • the list of operating parameters described above is not an exhaustive list and as such, other parameters may be modified manually or autonomously in the system.
  • the method 400 begins with the receipt 410 of an external input.
  • the input may include updates for FOB information, IOB information, medication details, or simply include a request for modification of one or more system parameters.
  • the input can be manually entered into the infusion pump via a control center, graphical user interface, bar code reader, radio frequency (RF) reader, optical reader, infrared reader, wireless transmission, email, text message, Internet, or other means.
  • RF radio frequency
  • the infusion pump may analyze 420 the received data to determine whether the input is a request to modify, or other system task. For example, a request for performing a calculation in the system may be carried out immediately, since the effect of performing the calculation is informational to the user (e.g., the calculation does not change a treatment parameter and may therefore be completed upon request). However, some requests include modifying medication levels or rates may require further analysis to determine whether or not to carry the request out, as received. When modifications are requested or proposed, further processing may be carried out using system data, input data, or stored data, and the user may be prompted to approve such modifications.
  • further calculations may be performed 430 to determine what effect, if any, the modification may have on the pump user. For example, a diabetic pump user may manually enter a food item that is about to be consumed. The pump user may wish to preemptively view FOB values and the corresponding bolus amount of insulin that will be infused if the user consumes the entered food. Here, the calculation can be performed and a suggested bolus amount can be presented to the pump user.
  • Calculation feedback, instructions, or other information may be presented 440 to the user audibly, visually, or via another sense, such as a vibration (e.g., such that the user can feel an alarm is being generated).
  • a vibration e.g., such that the user can feel an alarm is being generated.
  • the information is displayed to the user in a user interface, but multiple modes of presentation may be possible.
  • the user may input further information, make selections, or ignore the display.
  • the system may inquire about performing processes in the infusion pump.
  • the infusion pump may query the pump user to impart permission to perform 450 a modification in the system.
  • a request may have generated the query, or alternatively, the system may automatically generate the query to request permission for performing a system function.
  • a query may display to inquire about a preprogrammed event, such as a treatment change.
  • the pump user may receive queries in the graphical user interface that pertain to system processes, parameters, events, or other items.
  • the user may choose to respond to a query or request from the pump system.
  • a query is generated requesting permission to perform a system parameter modification
  • the user may choose to accept the modification.
  • the infusion pump system can perform 460 the requested modification.
  • the pump user may disapprove of a particular modification and thus may refuse permission to perform the modification. Additionally, the user may refuse permission and may enter modified information.
  • the modified information can be applied and the query may be regenerated such that the user can be presented the same query with the updated information.
  • input from the user may be accepted and implemented immediately and the system may not present another query to the user.
  • the infusion pump system can obtain 470 the user entered parameters or treatment correction and calculate 480 an appropriate modification.
  • the pump system may carry out 460 the requested modification(s).
  • the received input may not be a correction or modification, but instead may be additional information for the system to further process.
  • a user may input a request to modify a system parameter, but inadvertently leave out a digit or instruction regarding the parameter.
  • the system may not make the requested modification.
  • an indication of missing data may trigger an indicator, such as a display to the user, enabling the user to notice and correct the error.
  • FIG. 5 is a flow chart illustrating a method 500 of providing external input to modify infusion pump parameters.
  • the method 500 will be described in reference to an infusion pump system that can receive input.
  • pump users or medical staff can provide information to the pump system in various ways, including manual entry, or data entry by other methods, such as a transmission, automated data entry, or other method.
  • the user may provide updates for one or more system operating parameters, such as a bolus profile, basal rate, RTC, or BG history to name a few examples.
  • the user may provide food values or medication values to assist the pump system with future processing of calculations.
  • the user may provide a pump configuration request, whereby the pump system can reconfigure itself according to the input, or alternatively, the pump system can download or upload pump contents in preparation for a pump replacement. Other manually entered input may be possible.
  • the method 500 begins by receiving one or more inputs from the user. If the user inputs 502 update parameters, the system may receive 504 the input in a control module, for example.
  • the control module may determine the type of information entered. Accordingly, this may involve one or more queries to determine the purpose of the entry. Thus, the system may assess 506 whether or not a parameter update is being requested by the user. If the entered input is indeed a parameter update, the system may update 508 the parameter according to system rules. System rules may include various error checking mechanisms to ensure a particular parameter update does not endanger the health of the pump user. Upon completing the parameter update, the system may await another input from the user. The pump system may receive several entries and may have to distinguish between several types of input.
  • the user may enter 510 a food or medication value into the system, instead of a parameter update as described above.
  • the control module may determine 512 the type of information entered by the user. If the input is a food value or medication value, the system may perform processing steps to recalibrate parameter values such that the pump system functions to the user's advantage. For example, the user may enter food values for food about to be consumed. Accordingly, the pump system can perform calculations 514 to determine accurate treatment values for the user in the next several hours, for example.
  • the user may enter 516 pump configuration requests, such that a pump can be reconfigured or configured upon replacement.
  • the system may again use the control module to determine 518 the type of information entered by the user.
  • the configuration request may simply include resetting certain system parameters, while leaving others intact.
  • the user may request configuration of a newly installed pump system (e.g., upon replacement of an old pump system).
  • the system may perform 520 the configuration of the pump system.
  • the user may also enter 522 other types of input that the system may or may not recognize upon entry.
  • a database having various food values and their typical masses may be downloaded to the pump system.
  • the database can be used to compare typical “servings” of food items against what a user may consume.
  • the database may be uploaded wirelessly from the Internet and may require further user interaction to appropriately store and use the database in the pump system.
  • an onboard assistance device may assist 524 the user in walking through configuration steps to ensure the database operates properly.
  • the onboard assistance device may also intervene to assist the user for other unknown data entries.
  • FIG. 6 is a flow chart illustrating a method 600 of analyzing received criteria to determine or enhance a bolus amount in an infusion pump system.
  • the method 600 will be described in reference to an infusion pump system that analyzes user input to determine system parameter values, such as bolus amounts and rates.
  • the method 600 may provide manual control of the infusion pump system by means of a device or program which assists the pump user with determining proper bolus amounts.
  • timing is a key issue in the delivery of insulin. This can make it difficult to adjust insulin levels in the body to an appropriate level. This may be compounded by the fact that most diabetics test their BG levels after they finish eating, sometimes significantly later than the start of the meal. Accordingly, external systems such as infusion pumps may be designed to account for time anomalies and the like when delivering medication to a pump user.
  • users may have different profiles as relate to digestion and metabolism. For example, a user may have different glucose sensitivity than other users, and be able to tolerate a higher or lower level of glucose. These particular individuals' metabolism may correlate to different glucose levels in the blood as a result of the same specific food intake. As another example, a user may have different insulin sensitivity in which the same amount of insulin will have a different effect on the Blood glucose level in the bloodstream. In addition, the metabolism time of glucose and insulin for one user may be faster or slower than for other users.
  • the method 600 begins when the infusion pump system receives 610 input from a pump user.
  • food on board (FOB) and insulin on board (IOB) values can be received in the pump system.
  • FOB is a measurement of food previously consumed by a user.
  • FOB is a measurement of food that has been consumed by a user, but not yet converted into glucose usable by the body for metabolism.
  • IOB is a measurement of the insulin previously dosed to a user.
  • IOB is a measure of the insulin that has been dosed to a user but not yet available for the metabolic process (i.e., insulin that has not yet been absorbed into the bloodstream).
  • IOB is a measure of the total insulin in a user's system, including insulin in the bloodstream or in the tissues. Thus, it may be a measure of all insulin that has not yet been metabolized.
  • the system may use the FOB and IOB to calculate bolus amounts.
  • pumps may be designed to determine and utilize information concerning the individual user.
  • individual parameters such as sensitivity to insulin, carbohydrates or other endocrine information may allow the pump to improve recommended treatments.
  • the pump system may utilize food input and BG level input to accurately determine when a particular meal was started, when a peak glucose level will occur, and/or what an uncorrected BG level should be.
  • An onboard assistance system may include a processing method, for example, which incorporates carbohydrate, protein, and fat values to determine a value for food on board (“FOB”) for the user.
  • the FOB calculation might correspond to the equivalent amount of carbohydrate for each of the protein and fat intakes.
  • the pump user may request a task, and be given further assistance by the onboard assistance system to carry out the task with accuracy.
  • the onboard assistance program may include a monitoring method that incorporates previously entered data and treatment information to determine a value for insulin on board (“IOB”) for the user.
  • IOB insulin on board
  • an IOB feature in a pump calculates the decay of insulin in the body after a bolus of insulin is given to a pump user.
  • the infusion pump system may recognize current dosage levels that a user is receiving and further, can measure the dosage to determine future infusion dosages or rates.
  • the pump user can input several variables that the pump system can utilize to recommend one or more treatments.
  • using an infusion pump having manual and autonomous control properties may allow an accurate estimate of a particular bolus rate or amount.
  • the pump user may have flexibility in entering and modifying the bolus rate or amount at any time.
  • the bolus amount determined by the above equation may be modified or enhanced 630 based on a BG correction factor.
  • the BG correction factor may be calculated as the difference between the measured BG level and the target BG level. This difference, if any, may assist the pump user in determining if a midstream bolus correction factor is required or desired, as well as determine the potential magnitude of correction.
  • the measured BG level is a function of time against foodstuffs intake and calculated by the formula described above.
  • the BG correction factor may be determined by the maximum BG level whereby the maximum BG level is an individually determined number.
  • the maximum BG level may be based on factors including prior history, experience, and desired treatment levels, and may be set by the user or a health care provider.
  • the maximum BG level may be input and the bolus correction factor may then be calculated based on the maximum BG level. This may assist the pump user in determining if a midstream bolus correction factor may be required or desired, as well as determining the potential magnitude of correction.
  • the maximum allowable BG may be provided as input to the pump.
  • the pump may analyze the input and suggest an appropriate bolus amount and corresponding timing. This information may also allow the pump to suggest 640 midstream corrective actions, such as a modification to an immediate or delayed bolus, additional BG checks or other recommended changes such as temporary suspension of therapy. If the infusion pump suggests a midstream bolus correction, a magnitude of correction can be determined 650 in the pump system.
  • the infusion pump may calculate a bolus amount based on information including the total intake of grams of carbohydrates, fat and protein, as well as the timing of the intake. A bolus amount may be recommended by calculating 620 system parameters. The outcome of the calculations may be made available 660 to the pump user in the user interface, for example.
  • a delayed bolus feature may be implemented to provide further precision in controlling a pump user's BG levels. For example, anticipating what a BG level may be after consumption of an entered foodstuff may allow the pump system to properly dose the pump user at an opportune time.
  • the delayed bolus may be user selectable. For example, pump users may enter the time at which a particular foodstuff was consumed and set a time to receive a dose of insulin.
  • the modified treatment amount determined by the pump system may include the use of additional factors not normally used in infusion pump systems such as insulin pumps.
  • the advantages of using additional information may include obtaining a treatment that is individually suited to the user, obtaining a treatment that has a better time profile to better match actual food consumption and medicament infusion, obtaining a treatment based on additional foodstuff information, or obtaining a treatment that is based in part on user metabolism.
  • the additional information may be available due to increased processing and memory abilities, new ways of looking at ways to utilize information, and new methodologies to obtain information. For example, asking a user to enter a large amount of foodstuff information leads to low compliance. However, methods described herein enable easy entry of foodstuff information, resulting a better compliance and ability to utilize information.
  • FIG. 7 is a flow chart illustrating a method 700 of postponing disruptive alert messages in an infusion pump system.
  • the method 700 will be described in reference to an alert messaging system in an infusion pump.
  • the alert messaging system may alert a pump user audibly, visually, or via another sense, such as a vibration (e.g., such that the user can feel an alarm is being generated).
  • Visual indicators can include light emitting diodes (LEDs), touch screens, liquid crystal display (LCD) screens, or other visual devices.
  • Audio indicators may include buzzer chips, piezoelectric indicators, or other technology, and the like.
  • the alert messaging system can generate a disruptive alert to inform the user of an event.
  • the alert messaging system may accept input from pump users, such as time, date and alarm or alert criteria.
  • the pump user may manually configure an alert-free period to suspend the receipt of the alerts for a set period of time (e.g. 4 hours).
  • the pump user may manually request a suspension of the disruptive alerts until a certain specified time is reached (e.g. suspend until 6 am).
  • the pump may not produce or present audible, visual, or other disruptive alerts in that specified time period.
  • the pump may be programmed to defer the alerts to either the resumption time or the end of time of the alert-free period.
  • the method 700 begins with the receipt 710 of a request for postponement of alert messages.
  • the pump user may enter a request for an alert-free period, or the system may activate a previously set alarm.
  • Alert-free periods and alarms may be manually set by the pump user at any time.
  • preemptive alerts may be set in the pump system and may automatically engage at a set time.
  • the infusion pump may disable 720 one or more indicators for the suspended alert.
  • certain types of disruptive alerts may be suspended and replaced by other alert types.
  • the alert messaging system may replace audible or visual indicators with a vibration indicator, so that the pump will vibrate to provide an alert.
  • a pump user may wish to suppress audio indicators for a long period of time, such as, during a seminar or meeting. Thus, the user may temporarily suspend audio alert indicators, but may still receive visual messaging and indicators.
  • all disruptive alerts may be suspended until a set time.
  • the period of time may be determined by a requested period of time or may be determined by the period of time until the requested resumption time.
  • the method 700 may make inquiries over time to determine 730 whether or not the alert suppression time has expired. If the time has not completed, the suppression remains in progress and the system awaits expiration of the suppression time. If, however, the suppression time has expired, the alert indicators may be enabled 740 and the system may function accordingly. In addition to suspending alert messages, the pump system may also receive instructions to suspend other processes.
  • a health alert or alarm system may remain active even while the disruptive alert system has been disabled.
  • Disruptive alerts generally relate to events, such as dispensing a bolus amount, a programmed change in infusion amounts, a reminder to check blood glucose levels, etc.
  • Health alerts generally relate to health-critical events, which may have a significant health impact on the user if not addressed. Examples of events that may generate a health alerts include the container of medicine in the infusion pump reaching a low level, the container of medicine in the infusion pump being empty, a sensed blockage of flow from the infusion pump, or other events. As these events have a high priority, a health alert or alarm system may remain functional even during a requested alert suspension period.
  • the alert system used by the pump devices may be very disruptive and irritating. These disruptive alerts generally inform the user that a dosage has occurred, that a requested bolus was delivered, or other event. In many cases the user may already know that the event will be occurring.
  • the advantages of disabling a disruptive alert system includes the advantages of turning off such alerts during meetings, during rest periods, or during periods requiring enhanced concentration. This enables the user (and others) to perform at an optimal level without distraction for a requested period. After the requested period, the pump system will automatically return to normal operation. Thus, no additional input or request is needed to return to normal operation.
  • alarms may be very important to the user, such as health alerts, that inform the user of a critical failure, problem, or other issue. These alarms may remain enabled even during the requested period for disabling disruptive alerts. This provides additional assurance and peace of mind to the user that critical alarms will not be missed.
  • FIG. 8 is a flow chart illustrating a method 800 of postponing medication dispersion in an infusion pump system.
  • the infusion pump may be equipped with a feature whereby the delivery of medication may be suspended temporarily at a specified time.
  • the method 800 begins when the duration and time of suspension are entered 810 by the pump user, such as a patient or nurse, and the system can alert the user of the suspended status at a predetermined interval or period of time.
  • the input can be manually entered into the infusion pump via a control center, graphical user interface, bar code reader, radio frequency (RF) reader, optical reader, infrared reader, wireless transmission via email or Internet, or other means suitable to enter data into a processing device.
  • RF radio frequency
  • the system may disable 820 the medication delivery system.
  • the delivery of medication may be automatically or manually restarted after a predetermined period of time.
  • the system may periodically assess 830 whether or not the entered suspension time has expired. If the suspension time has not expired, the system may continue to suspend medication and additional assessments may be performed in the future.
  • the medication delivery system may be enabled 840 for various reasons.
  • expiration of the suspension time may invoke the pump system to enable the medication delivery system.
  • a pump user may interrupt the medication delivery suspension to receive medications.
  • the pump user may be feeling symptoms that may require medication.
  • FIG. 9 is a flow chart illustrating a method 900 of transferring infusion pump parameters to one or more devices.
  • the pump system may need to be replaced to ensure proper treatment of the user.
  • the components in a pump may wear out and require replacing.
  • the pump system may include a mechanism portion, and a control portion that may be communicably coupled and uncoupled when either portion is replaced.
  • the mechanism portion may be detachable and disposable, while the control portion remains intact.
  • an old pump mechanism may be replaced by a new pump mechanism.
  • the entire pump system may be a single unit, with non-detachable mechanism and control portions.
  • the mechanism and control portions may be integrated.
  • the method of autonomous control may be initiated for a new or previously unused pump by the transfer of parameters from a current pump system to initiate proper operation.
  • the program and information may be the entire set of parameters including, but not limited to, bolus profile, basal rate, real time clock (“RTC”), blood glucose history, delivery history, and bolus history.
  • RTC real time clock
  • the transfer of parameters may be accomplished by transfer from an active or previously programmed unit or a separate programming device to a new, unused or unprogrammed unit. Parameters can be transferred to the new pump by either wired or wireless communications.
  • the method 900 begins when the infusion pump system receives 910 a request to transfer parameters.
  • a pump user may manually enter a request to upload or download pump operating parameters or feedback of suggested manual parameters to a database, another pump, the Internet, or various computer programs or computer files, to name a few examples.
  • the data to be transferred can be stored internally or externally before a transfer is performed.
  • the method of autonomous control may be initiated for a new or previously unused pump by the automatic transfer of parameters by which the pump may initiate proper operation.
  • operating parameters may include, but are not limited to, bolus profile, basal rate, RTC, BG history, delivery history, and bolus history.
  • the transfer of parameters may be accomplished by transfer from an active or previously programmed unit to a new, unused or unprogrammed unit.
  • the transfer of parameters may be downloaded to a database and uploaded to the unprogrammed unit at another time.
  • a new or unprogrammed pump may have the program and information loaded from a separate programming device.
  • the separate programming device may be connected to an external computer or device with an interface that may run on graphical user interface (GUI) standards associated with that computer.
  • GUI graphical user interface
  • the pump user may determine 920 a sending device from which the parameters and feedback will be transferred.
  • the sending device may be the current pump device.
  • the sending device may be a database, a digital computing device such as a laptop, desktop, workstation, personal digital assistant, server, or another device communicably coupled to the system.
  • the user may determine 930 the method of transfer.
  • This transfer may be initiated by means of direct, pump-to-pump physical contact, an infrared port, wireless connection, or by method and means of a wired connection, such as through a USB port, a serial port, or other technologies.
  • the information transferred may provide a seamless transition between the “old” pump (sending device) and the “new” pump.
  • Using a wired connection to transfer the parameters may facilitate communication by way of acoustic, electromagnetic, optical or other form of signaling. Ideally, the connection may be made and the transfer of information may be completed before the use of the pump.
  • the transfer of parameters can also be accomplished using wireless communication between the pumps.
  • the wireless transfer of parameters or files can be sent from the sending device to a receiving device (e.g., a new infusion pump) through a wireless connection, such as Bluetooth, Ethernet, or wireless Ethernet, to name a few examples.
  • the receiving device may be configured 940 appropriately to receive data.
  • memory on the device may be erased or configured to receive an upload of data, or other parameters, such as alert systems and displays may be tested for proper functionality.
  • the communication link may be tested 950 to ensure proper bandwidth or sufficiency of streaming. The communication link may fail prior to or concurrently with the initiation of the transfer. In this example, one or more configuration programs may be performed again, in an attempt to repair the link.
  • the parameters may be transferred 960 to the new pump.
  • the pump user may manually enable other systems on the new pump, install medication supplies, or enter further data.
  • the pump system may indicate, visually or audibly, that further action is required from the pump user.
  • the new pump system may perform a system check routine to ensure the pump will properly operate.
  • Direct communication from pump to pump enables a user to transfer operating history, user information, configuration parameters, and other information directly form one unit to another.
  • the advantages of such an approach may include the ability to make such a transfer without requiring any additional equipment or setup.
  • An approach that requires, for example, uploading and downloading from an internet site requires an internet connection, access to the specific site, and additional equipment. The user may not have all of these elements when a pump unit begins to fail.
  • pump to pump direct transfer enables the information to be captured in a new pump unit rather than lost in cases where the website is down for maintenance, the internet connection is slow or non-existent, or the user is on vacation or other location where additional equipment may not be present.
  • Direct communication from pump nit to pump unit also enables the use of disposable pump units, while still retaining information and history.
  • direct pump information transfer may transfer identification, configuration, and user information, resulting in an easy and direct initialization of a second pump unit.
  • operating history, historical dosage and consumption information may be transferred directly to a new pump unit.
  • the user may completely replace the equipment used, but have the full information available in the new unit.
  • a pump unit is “dumb”, and contains no processing or memory storage.
  • a “smart” pump unit enables the use and transfer of information from the pump unit itself. Incorporating processing and memory capacity into the pump unit enables the use and transfer of additional information from one pump unit to another.
  • FIG. 10 is a flow chart illustrating a method 1000 for entering food data into an infusion pump to receive a treatment recommendation.
  • the method 1000 begins when personal user information is obtained 1010 from the user, or alternatively, accessed from the pump system.
  • the pump user may manually enter personal information such as weight, medication ingested, exercise performed, or other health characteristics, and the system will store that data until needed in system analysis, for example.
  • the personal user information can be used for analysis in determining recommended treatments or other suggestions for the pump user.
  • the user may enter 1020 food information pertaining to food ingested for the day, or food about to be ingested. For example, the user may wish to know how much of a specific food item can be ingested without requiring medication. In another example, the user may simply wish to view statistics regarding prior consumption of the entered food.
  • the entered data may be analyzed, or compared 1030 with personal user information to determine proper bolus amounts and rates.
  • the system may internally determine the parameters for FOB and recommended bolus amount such as the example described in FIG. 3 above.
  • the comparison 1030 may be performed to increase or decrease a medication dosage. For example, if the pump user has ingested a particularly high quantity of sugar filled food in one day, an analysis may be performed to determine whether or not to increase the insulin dosage.
  • user entered data may be used to determine 1040 any number of recommended treatments to benefit the health of the pump user.
  • Recommended treatments may include medication dosages, consultant notices (e.g., consult a physician), technical support (e.g., to repair the pump for some reason), or simply recommendations on food consumption (e.g., dietary recommendations) and the like. Other treatment recommendations are possible in the system.
  • Some, all, or none of the determined treatments may be presented 1050 to the pump user in the user interface of the pump device.
  • the pump user may accept, modify, or decline a proposed treatment.
  • treatment recommendations may typically await user feedback before carrying out the actual treatment.
  • the recommended treatment may require a doctor's visit.
  • the pump system may carry out the recommended treatment after the user accepts the treatment.
  • device-assisted data entry may be used to enter foodstuff information.
  • a user may be willing to enter carbohydrate information related to the food consumed.
  • requesting additional information generally results in poor compliance.
  • Using device-assisted data entry provides a method of obtaining additional foodstuff information that may be useful in determining recommended treatment amounts of a medicine or other material.
  • Examples of device-assisted data entry include the use of barcode information, RFID tags, or food codes.
  • the information may enter the pump system via various communication interfaces, such as those shown in the example embodiment of FIGS. 1-3 .
  • the data entered may include foodstuff information directly, such as amount of calories, carbohydrates, fats, and proteins.
  • the data entered may be used as a key or code by the system to obtain additional foodstuff information.
  • a database having various food values including carbohydrate, fat, and protein content
  • the database can be used to compare typical “servings” of food items against what a user may consume.
  • the device-assisted data entry may enter a code value, which is then looked up in the database by the system to obtain various food values.
  • the database may be provided as part of the pump system, may be uploaded wirelessly from the Internet, and/or may require further user interaction to appropriately store and use the database in the pump system.
  • an onboard assistance device may assist 524 the user in walking through configuration steps to ensure the database operates properly.
  • the onboard assistance device may also intervene to assist the user for other unknown data entries.
  • the advantages of such an approach include the ability to utilize additional foodstuff information for the treatment of the user.
  • the additional foodstuff information may be obtained without requiring numerous additional steps or tasks by the user, and in same cases may require less input from a user.
  • an approach that includes additional foodstuff information, enabling better treatment may be easier for the user.
  • this approach may also increase user compliance with entering food and consumption information.
  • the methods 400 - 1000 may be performed by processing devices, such as those shown in FIG. 12 of this description.
  • the processing devices may be located in a control unit, in the pump body, or in some combination thereof.
  • the system may select one or more devices, from the system in FIG. 12 or another system, to perform the operations in the methods.
  • the input received in the system, or as part of the above operations may be received in a user interface, such as through a touch screen, keyboard, or other manual entry device, a data collection device, such as can be connected to interfaces 212 , 214 , or 216 .
  • FIG. 11 is simply one exemplary system for performing the operations in FIGS. 4-10 . Accordingly, the above description of example embodiments does not define or constrain this disclosure to a particular system. Other changes, substitutions, and alterations are also possible without departing from the spirit and scope of this disclosure.
  • FIG. 11 is a block diagram illustrating an exemplary architecture 1100 for operating and controlling an infusion pump system.
  • the architecture 1100 may receive user instructions in one or more communication interfaces, such as the infrared port 212 , USB port 214 , RFID reader 216 , or another attached interface, and may then implement the user instructions accordingly.
  • the architecture may respond to user instructions or requests with inquiries about the user entered instructions. For example, if a foodstuff is received via the RFID reader 216 , the architecture 1100 may respond to request a particular mass for the entered foodstuff.
  • the architecture 1100 includes a control unit 1102 and a pump unit 1104 that may be communicably coupled through interface 1106 .
  • the interface 1106 facilitates wireless, wired, contact, near proximity, or contactless communication between the control unit 1102 and the pump unit 1104 . While illustrated as a single or continuous interface, the interface 1106 may be logically divided into individual interfaces on either unit 1102 or 1104 without departing from the scope of this disclosure, so long as at least a portion of the interface 1106 may facilitate communications between the control unit 1102 and the pump unit 1104 .
  • the control unit 1102 may include various modules to perform functions in the pump system.
  • the modules may include a user interface module 1108 , a user assistance module 1110 , a configuration module 1112 , a control communication module 1114 , and a processing module 1115 .
  • the modules may interact with the pump user, the pump unit 1104 , and other system components, as necessary to carry out system tasks. For example, the modules may control the dispensing of medication by controlling the reservoir 105 .
  • the modules may be stored in a nonvolatile storage location, such as data repository 1116 or another repository in the system, and may be transferred to memory 1116 for active use by the architecture 1100 .
  • the user interface module 1108 may provide the user with a mechanism to input data into the pump system.
  • the user interface module 1108 may also display system information to the pump user, such as BG history or recommended bolus information, for example.
  • the user assistance module 1110 may provide guidance and recommendations to the user when a system function is scheduled, or when the user has requested a system modification. In some implementations, the user assistance module 1110 may provide suggestions and calculation values to assist the user in determining a course of action for the pump system.
  • the configuration module 1112 may configure the pump system upon user request.
  • pump components such as the drive mechanism 202 can be configured to the pump system parameters upon receiving a request from the pump user.
  • the configuration module 1112 may configure a new pump upon installation.
  • the configuration module 1112 may be user controlled, and thus, may not have prior system settings. For example, pump users may input personal information to “calibrate” the configuration module 1112 to appropriate settings.
  • the control communication module 1114 may receive user information via the user interface module 1108 , a barcode reader, an RF reader, a PDA, a cell phone, or other such technology, and transfer the data to the pump unit 1104 .
  • the control communication module 1114 may transfer user entered data, calculation data, modification data, operating instructions, and the like to the pump unit 1104 .
  • the pump unit 1104 may then carry out any instructions, or user modifications that the control unit 1102 deemed necessary.
  • the processing module 1115 may include one or more processors to execute instructions and manipulate data for performing the operations of the control unit 1104 .
  • the processing module 1115 may include a central processing unit (CPU), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or other suitable hardware or software control system, for example.
  • the control unit 1102 may include local electronic storage capacity, such as data repository 1116 .
  • the data repository 1116 may include any memory or database module and may take the form of volatile or non-volatile memory including, without limitation, magnetic media, optical media, random access memory (RAM), read-only memory (ROM), removable media, or any other suitable local or remote memory component.
  • the illustrated data repository 1116 may store system data, such as alert data, food data, medication data, reporting files, system parameters, user entered data, and others.
  • the pump unit 1104 may include a pump communication module 1118 , pump controls 1120 , and a pump mechanism 1122 .
  • the pump communication module 1118 may receive instructions from the control communication module 1114 . Specifically, user instructions or requests may be entered into the user interface module 1108 of the control unit 1102 , whereby, the control communication module 1114 may transfer the instructions or requests into the pump communication module 1118 . The module 1118 may then provide the information to the pump controls 1120 which may translate the instructions for the pump mechanism 1122 .
  • the pump controls 1120 may include one or more processors to execute instructions and manipulate data for performing the operations of the pump unit 1104 .
  • the pump controls 1120 may include, for example, CPUs, ASICs, FPGAs, or other suitable hardware or software control system.
  • the pump controls 1120 translate instructions for the pump mechanism 1122 .
  • the pump mechanism 1122 may deliver medication dosages to the pump user.
  • the pump mechanism 1122 can deliver a medication such as insulin in a basal dose, or a bolus dose to correct BG levels in the pump user's body.
  • control unit 1102 may be included as a portion of the pump unit 1104 . In other implementations, the control unit 1102 may be a separate, detachable entity from the pump unit 1104 . Regardless of whether or not the control unit 1102 and the pump unit 1104 are separate entities, in operation, system processing may occur in the control unit 1102 , in the pump unit 1104 , or may occur in a combination of both.
  • FIG. 12 is a schematic diagram of an example of a generic infusion pump computing system 1200 .
  • the system 1200 can be used for the operations described in association with the methods in this disclosure according to one implementation.
  • the system 1200 may be included in any or all of the computing system 800 , the pumps 900 , 1000 or 1100 .
  • the system 1200 includes a processor 1210 , a memory 1220 , a storage device 1230 , and an input/output device 1240 .
  • Each of the components 1210 , 1220 , 1230 , and 1240 are interconnected using a system bus 1250 .
  • the processor 1210 is capable of processing instructions for execution within the system 1200 .
  • the processor 1210 is a single-threaded processor.
  • the processor 1210 is a multi-threaded processor.
  • the processor 1210 is capable of processing instructions stored in the memory 1220 or on the storage device 1230 to display graphical information for a user interface on the input/output device 1240 .
  • the processors shown in FIG. 12 may be included in some, all, or none of the modules shown in FIG.
  • the processors and modules may be located within a pump body (such as the example pump body shown in FIGS. 1-3 ), or may be located within a control unit. In some embodiments, the control unit may be detachable from the pump body. In some embodiments, some of the modules or processors may be located in a control unit, while others are located within a pump body.
  • the memory 1220 stores information within the system 1200 .
  • the memory 1220 is a computer-readable medium.
  • the memory 1220 is a volatile memory unit.
  • the memory 1220 is a non-volatile memory unit.
  • the storage device 1230 is capable of providing mass storage for the system 1200 .
  • the storage device 1230 is a computer-readable medium.
  • the storage device 1230 may be a floppy disk device, a hard disk device, an optical disk device, or a tape device.
  • the input/output device 1240 provides input/output operations for the system 1200 .
  • the input/output device 1240 includes a keyboard and/or pointing device.
  • the input/output device 1240 includes a display unit for displaying graphical user interfaces.
  • the features described can be implemented in digital electronic circuitry, or in computer hardware, firmware, software, or in combinations of them.
  • the apparatus can be implemented in a computer program product tangibly embodied in an information carrier, e.g., in a machine-readable storage device or in a propagated signal, for execution by a programmable processor; and method steps can be performed by a programmable processor executing a program of instructions to perform functions of the described implementations by operating on input data and generating output.
  • the described features can be implemented advantageously in one or more computer programs that are executable on a programmable system including at least one programmable processor coupled to receive data and instructions from, and to transmit data and instructions to, a data storage system, at least one input device, and at least one output device.
  • a computer program is a set of instructions that can be used, directly or indirectly, in a computer to perform a certain activity or bring about a certain result.
  • a computer program can be written in any form of programming language, including compiled or interpreted languages, and it can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment.
  • Suitable processors for the execution of a program of instructions include, by way of example, both general and special purpose microprocessors, and the sole processor or one of multiple processors of any kind of computer.
  • a processor will receive instructions and data from a read-only memory or a random access memory or both.
  • the essential elements of a computer are a processor for executing instructions and one or more memories for storing instructions and data.
  • a computing system will also include, or be operatively coupled to communicate with, one or more mass storage devices for storing data files; such devices include magnetic disks, such as internal hard disks and removable disks; magneto-optical disks; and optical disks.
  • Storage devices suitable for tangibly embodying computer program instructions and data include all forms of non-volatile memory, including by way of example semiconductor memory devices, such as EPROM, EEPROM, and flash memory devices; magnetic disks such as internal hard disks and removable disks; magneto-optical disks; and CD-ROM and DVD-ROM disks.
  • semiconductor memory devices such as EPROM, EEPROM, and flash memory devices
  • magnetic disks such as internal hard disks and removable disks
  • magneto-optical disks and CD-ROM and DVD-ROM disks.
  • the processor and the memory can be supplemented by, or incorporated in, ASICs (application-specific integrated circuits).
  • ASICs application-specific integrated circuits
  • the features can be implemented on a computing device or infusion pump device having a display device an LCD (liquid crystal display) monitor for displaying information to the user and a keyboard, keypad, or pointing device by which the user can provide input to the computer.
  • a display device an LCD (liquid crystal display) monitor for displaying information to the user and a keyboard, keypad, or pointing device by which the user can provide input to the computer.
  • LCD liquid crystal display

Abstract

A method and system for both autonomous and manual control of an infusion pump for delivering medication to a patient is provided.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. provisional application 60/734,398, filed Nov. 8, 2005. The disclosure of the prior application is considered part of and is hereby incorporated in its entirety by reference in the disclosure of this application.
TECHNICAL FIELD
The present invention relates to autonomous and manual control of an infusion pump.
BACKGROUND
An infusion pump is used to infuse fluids, medication or nutrients into a patient's circulatory system. It is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used.
Infusion pumps can administer fluids in ways that would be impractically expensive or unreliable if performed manually. For example, infusion pumps can administer 1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to the maximum number per hour allowed (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.
As infusion pumps can also produce quite high but controlled pressures, the pumps can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system—a very popular local spinal anesthesia for childbirth).
SUMMARY
A method and system is provided for both autonomous and manual control of an infusion pump for delivering medication to a patient. The manual control may provided by an onboard assistance device allowing the user to make entries and corrections.
A method for directly transferring operating parameters from one infusion pump device to a second infusion pump device is described that includes providing a first infusion pump device including parameters to be transferred, establishing a communications link from the first infusion pump device to a second infusion pump device, and transferring the parameters from the first infusion pump device to the second infusion pump device.
Variously, the communication link may be established using wired means, by contact between the first infusion pump device and the second infusion pump device, or by using wireless means. Variously, the parameters may include historical treatment information, may include user information, or may include operating parameters.
A method of entering food information into an infusion pump system is described that includes providing a foodstuff identification, and using device assisted data entry to enter the foodstuff identification into an infusion pump system. The method may also include using the entered foodstuff identification to retrieve foodstuff composition information.
Variously, the foodstuff identification may include a barcode, or may include an RFID tag. Variously, the foodstuff identification may be entered using a scanner in an infusion pump system, or may be entered using an RFID reader in an infusion pump system.
An infusion pump system is described that includes an infusion pump body, a control system, and an RFID reader, wherein the RFID reader is in communication with the control system. The RFID reader may be contained within the infusion pump body, or form part of the infusion pump body.
A method for temporarily disabling a disruptive alert of an infusion pump system is described that includes receiving a request to disable disruptive alerts from an infusion pump system for a specified period of time, disabling disruptive alerts from the infusion pump system for the specified period of time, and re-enabling disruptive alerts after the specified period of time has passed. Health alerts may remain active during the specified period of time.
Variously, the specified period of time may be determined by the difference between the current time and a requested time, or the specified time may be determined by a request for a specified time period.
A method of determining a treatment amount for an infusion pump system is described that includes obtaining treatment information including foodstuff composition information, food on board information, and insulin on board information, and determining a recommended bolus amount based on the treatment information.
Variously, the foodstuff composition information may include a carbohydrate ratio, may include quantity information, or may include carbohydrate, fat, and protein information.
The method may also include using user metabolism information in calculating a bolus amount. Variously, user metabolism information may include insulin sensitivity information, or glucose sensitivity information.
A method of determining a treatment amount for an infusion pump system is described that includes obtaining foodstuff composition information including carbohydrate, fat, and protein composition information of a foodstuff; and determining a recommended bolus amount based on the foodstuff composition information.
Determining a recommended bolus amount may also be based on user metabolism information, or may also be based on a user's food on board and insulin on board information. The foodstuff composition information may be entered into the infusion pump system using device assisted data entry.
A method of determining a recommended bolus amount is described that includes obtaining user metabolism information, obtaining foodstuff composition information including carbohydrate, fat, and protein composition information using device assisted data entry, and determining a recommended bolus amount using the following equation:
Recommended bolus amount=Food Now*Carb Ratio+(BG−BGtarget)*insulin sensitivity−IOB+FOB,
where:
    • FOB=f(t)*bolus;
    • FOB=f(t)*grams Carb Ratio+f(t)*grams Protein Ratio+f(t)*grams Fat ratio; and
    • Food Now=the amount and type of foodstuffs ingested expressed in terms of grams, carbohydrates, proteins or fat.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description, drawings, and from the claims.
DESCRIPTION OF DRAWINGS
FIG. 1 is an illustration of an exemplary infusion pump system.
FIG. 2 is an illustration of a cross sectional view of the exemplary infusion pump system of FIG. 1.
FIG. 3 is an illustration of transferring data between two infusion pump systems.
FIG. 4 is a flow chart illustrating a method of assisted modification of infusion pump parameters.
FIG. 5 is a flow chart illustrating a method of providing external input to modify infusion pump parameters.
FIG. 6 is a flow chart illustrating a method of analyzing received criteria to determine or enhance a bolus amount in an infusion pump system.
FIG. 7 is a flow chart illustrating a method of postponing alert messages in an infusion pump system.
FIG. 8 is a flow chart illustrating a method of postponing medication dispersion in an infusion pump system.
FIG. 9 is a flow chart illustrating a method of transferring infusion pump parameters to one or more devices.
FIG. 10 is a flow chart illustrating a method for entering food data into an infusion pump to receive a treatment recommendation.
FIG. 11 is a block diagram illustrating an exemplary architecture for operating and controlling an infusion pump system.
FIG. 12 is a schematic diagram of an example of a generic infusion pump computing system.
DETAILED DESCRIPTION
A method and system for autonomous and manual control of an infusion pump system is described. The system may receive input, analyze input, display some or all analysis data to an infusion pump user, and may perform modifications to one or more infusion pump parameters. The infusion pump system may automatically prompt the user to perform a system task or modification. For example, when a blood glucose (“BG”) reading is dangerously high in the pump user, the system may prompt the user with information regarding decisions on dispensing medication or nutrients into the pump user's circulatory system, such as insulin medication to lower the BG level in the user. The user can then perform various tasks, including, but not limited to, ignoring the prompt, implementing the suggested protocol, or modifying the suggested protocol before implementing the modified protocol. In one embodiment, upon receiving a user requested modification, the system may present and display information to the user indicating that the infusion pump parameters should remain unchanged.
The methods described in this application can be performed manually based on a request from a pump user, automatically based on previously entered user data (e.g., an alarm or criteria set by the user), or a combination of both. The manual control may be provided by an onboard assistance system to allow the pump user to make entries and corrections in the system.
FIG. 1 is an illustration of an exemplary infusion pump system 100 that may be used to perform the methods described in this disclosure.
The infusion pump system 100 includes a pump body 102, an infusion site interface 104, and a reservoir 105. The pump body 102 includes an upper housing 106 and a lower housing 108 which define a periphery in which the mechanisms of a pump unit reside. The upper and lower housings 106, 108 may include openings or penetrations for attachment and guidance of the infusion site interface 104 to the pump body 102. Additionally, openings in the pump body may allow for the installation of the reservoir 105 contained within the pump body 102, and maintenance of the reservoir 105 that may be in communication with the infusion site interface 104 for dispensing medication. In general, the infusion site interface 104 may provide for continuous or intermittent subcutaneous fluid infusion. One or more buttons 110 may be used to enter user requests into the pump system.
FIG. 2 is an illustration of a cross sectional view of the exemplary infusion pump system of FIG. 1.
As shown, a mechanism is contained in the pump body 102 that comprises the reservoir 105, a drive mechanism 202 and a control system (not shown). The reservoir 105 is comprised of a distal end 204 and a proximal end 206, and is cylindrical in geometry with the distal end 204 sealed by a moveable plunger 208 of matching geometry as the reservoir 105 and the proximal end 206 are contained by a pump body septum 210. The infusion pump system 100 generally dispenses fluid when the drive mechanism 202 is actuated, thereby applying pressure internal to the reservoir, such that a substance contained within the reservoir may be driven through a device (not shown) that may pierce the pump body septum 210. The actuation of the drive mechanism 202 may be governed by the control mechanism. The geometry of the reservoir 105 has been shown as cylindrical for illustrative purposes only and as such, the reservoir 105 is geometry independent.
In addition to the functionality of the pump system, the system may also include communication circuitry and functionality to upload, download or otherwise transfer data to and from the pump system. For example, the infusion pump system 100 may transfer, upload, or download data to a computer, a data repository, to itself, or to another infusion pump, to name a few examples. In particular, the infusion pump system 100 may include circuitry designed for sending and receiving data, such as communication chipsets including, but not limited to, universal serial bus (USB), RS-232, Ethernet, Bluetooth, radio frequency, infrared, wireless Ethernet, or other such technologies. As shown in FIG. 2, the system 100 may include an infrared port 212, a USB port 214, and a radio frequency identification (RFID) reader 216. In some implementations, rather than having an internal RFID reader, the infusion pump system may include circuitry for connecting an external RFID reader. In some implementations, some, all, or none of the above communication chipsets, connectors, or technologies may be included in the system, and as such, other ports and connector technologies are possible.
In some implementations, additional communication ports (not shown) may be available for connecting peripheral data collection devices. The data collection devices may be used to enter input into the infusion pump system. The data collection devices may include, but are not limited to, a bar code scanner, a radio frequency (RF) reader, an optical scanner, an infrared scanner, or other wired or wireless data collection device. The data collection device may allow data to be uploaded or entered into the pump system by selecting or scanning food and medication information, for example. In some implementations, the pump user may download data from a website, or other means where wired or wireless communication is available (e.g., a mobile telephone, or a personal digital assistant (PDA)).
The pump user may collect data for the infusion pump system in various ways. Device assisted data entry may be utilized to obtain additional information beyond that which may be easily entered using a manual approach. For example, a pump user may user the USB port 214 to plug in a barcode scanner, and can scan foodstuffs to obtain additional information, such as carbohydrate, fat, and protein amounts, mass, brand, food group, or other foodstuff identifying features. In other implementation, the infusion pump system may include an on-board barcode scanner. Using a barcode scanner, the user may scan the foodstuff item and enter one or more identifying features in the user interface. In some implementations, the pump user may use an onboard RFID reader 216 to scan RFID tags located on foodstuffs, rather than a barcode reader. In other implementations, a RFID reader may be plugged in a USB port or other input/output port. In other implementation, other device assisted data-entry approaches may be used. Furthermore, in other embodiments, wireless device assisted data entry implementations may be used (e.g., a wireless RFID reader or wireless barcode scanner may be used to communicate foodstuff information to the infusion pump system).
In some implementation, the foodstuff information may include a product identifier or code. The product identifier or code may be used to obtain additional product information from an onboard data repository. Thus, a UPC code may be used to identify a foodstuff, which is then looked up in a data repository to obtain nutrition and other information regarding the foodstuff.
Collecting data in the infusion pump system may be advantageous when calculating treatment methods for pump users. For example, data collection devices may also provide a method for entering food identification and composition information. The composition information may comprise a carbohydrate ratio, quantity information, carbohydrate content, fat content, or protein content. In some implementations, the collected data may be used to determine and recommend a particular bolus amount.
FIG. 3 is an exemplary illustration of transferring data between two infusion pump systems.
In general, a first pump 302 and a second pump 304 may establish pump-to-pump communications to transfer data between the pumps. Specifically, one or more communication ports on the pumps may initiate the communication. For example, an infrared port on the first pump 302 may initiate communication with an infrared port on the second pump 304 upon coming into close proximity. In some implementations, the communication may be a wired communication where a pump user has “connected” the pumps together (e.g., as in a USB to USB cable connection). Regardless of which pump initiated the connection, a portion of data may be bi-directionally transferred between both pumps, as facilitated by a pump user. In some implementations, no data may be transferred (e.g., when a pump user has not requested a transfer).
After the communication protocol is established, the transferring of data may commence. In particular, the processing devices on each pump may invoke their respective data repositories to begin transferring data between the pumps. In general, operating parameters, historical treatment data, user information, configuration data, pump user data, pump manufacturer data, medication on board, and other system information may be transferred from one pump to another pump.
FIG. 4 is a flow chart illustrating a method 400 of assisted modification of infusion pump parameters.
The method 400 will be described in reference to an infusion pump system that processes user requests and infuses fluids, medication, nutrients or other materials into the body of the pump user. The user requests may include various modifications to system operating parameters, such as modifications to bolus profile, basal rate, RTC, BG history, delivery history, bolus history, and others. The list of operating parameters described above is not an exhaustive list and as such, other parameters may be modified manually or autonomously in the system.
The method 400 begins with the receipt 410 of an external input. The input may include updates for FOB information, IOB information, medication details, or simply include a request for modification of one or more system parameters. The input can be manually entered into the infusion pump via a control center, graphical user interface, bar code reader, radio frequency (RF) reader, optical reader, infrared reader, wireless transmission, email, text message, Internet, or other means.
After the input is received, and after any optional pre-processing, the infusion pump may analyze 420 the received data to determine whether the input is a request to modify, or other system task. For example, a request for performing a calculation in the system may be carried out immediately, since the effect of performing the calculation is informational to the user (e.g., the calculation does not change a treatment parameter and may therefore be completed upon request). However, some requests include modifying medication levels or rates may require further analysis to determine whether or not to carry the request out, as received. When modifications are requested or proposed, further processing may be carried out using system data, input data, or stored data, and the user may be prompted to approve such modifications.
Upon completion of the analysis, further calculations may be performed 430 to determine what effect, if any, the modification may have on the pump user. For example, a diabetic pump user may manually enter a food item that is about to be consumed. The pump user may wish to preemptively view FOB values and the corresponding bolus amount of insulin that will be infused if the user consumes the entered food. Here, the calculation can be performed and a suggested bolus amount can be presented to the pump user.
Calculation feedback, instructions, or other information may be presented 440 to the user audibly, visually, or via another sense, such as a vibration (e.g., such that the user can feel an alarm is being generated). Typically, the information is displayed to the user in a user interface, but multiple modes of presentation may be possible. Upon presentation of the information, the user may input further information, make selections, or ignore the display.
In some implementations, the system may inquire about performing processes in the infusion pump. For example, the infusion pump may query the pump user to impart permission to perform 450 a modification in the system. In this example, a request may have generated the query, or alternatively, the system may automatically generate the query to request permission for performing a system function. In some implementations, a query may display to inquire about a preprogrammed event, such as a treatment change.
The pump user may receive queries in the graphical user interface that pertain to system processes, parameters, events, or other items. The user may choose to respond to a query or request from the pump system. In the event that a query is generated requesting permission to perform a system parameter modification, the user may choose to accept the modification. Upon receiving permission to perform the intended modification, the infusion pump system can perform 460 the requested modification.
Alternately, the pump user may disapprove of a particular modification and thus may refuse permission to perform the modification. Additionally, the user may refuse permission and may enter modified information. The modified information can be applied and the query may be regenerated such that the user can be presented the same query with the updated information. In some embodiments, input from the user may be accepted and implemented immediately and the system may not present another query to the user. The infusion pump system can obtain 470 the user entered parameters or treatment correction and calculate 480 an appropriate modification. Upon determining the modification requested, the pump system may carry out 460 the requested modification(s). In some implementations, the received input may not be a correction or modification, but instead may be additional information for the system to further process.
In some implementations, a user may input a request to modify a system parameter, but inadvertently leave out a digit or instruction regarding the parameter. In the event that data is missing or entered incorrectly, the system may not make the requested modification. In some implementations, an indication of missing data may trigger an indicator, such as a display to the user, enabling the user to notice and correct the error.
FIG. 5 is a flow chart illustrating a method 500 of providing external input to modify infusion pump parameters.
The method 500 will be described in reference to an infusion pump system that can receive input. Variously, pump users or medical staff can provide information to the pump system in various ways, including manual entry, or data entry by other methods, such as a transmission, automated data entry, or other method. In one embodiment, the user may provide updates for one or more system operating parameters, such as a bolus profile, basal rate, RTC, or BG history to name a few examples. In another embodiment, the user may provide food values or medication values to assist the pump system with future processing of calculations. In yet another embodiment, the user may provide a pump configuration request, whereby the pump system can reconfigure itself according to the input, or alternatively, the pump system can download or upload pump contents in preparation for a pump replacement. Other manually entered input may be possible.
The method 500 begins by receiving one or more inputs from the user. If the user inputs 502 update parameters, the system may receive 504 the input in a control module, for example. The control module may determine the type of information entered. Accordingly, this may involve one or more queries to determine the purpose of the entry. Thus, the system may assess 506 whether or not a parameter update is being requested by the user. If the entered input is indeed a parameter update, the system may update 508 the parameter according to system rules. System rules may include various error checking mechanisms to ensure a particular parameter update does not endanger the health of the pump user. Upon completing the parameter update, the system may await another input from the user. The pump system may receive several entries and may have to distinguish between several types of input.
In some implementations, the user may enter 510 a food or medication value into the system, instead of a parameter update as described above. The control module may determine 512 the type of information entered by the user. If the input is a food value or medication value, the system may perform processing steps to recalibrate parameter values such that the pump system functions to the user's advantage. For example, the user may enter food values for food about to be consumed. Accordingly, the pump system can perform calculations 514 to determine accurate treatment values for the user in the next several hours, for example.
In some implementations, the user may enter 516 pump configuration requests, such that a pump can be reconfigured or configured upon replacement. Here, the system may again use the control module to determine 518 the type of information entered by the user. The configuration request may simply include resetting certain system parameters, while leaving others intact. In another example, the user may request configuration of a newly installed pump system (e.g., upon replacement of an old pump system). Upon determining that the user has requested a pump configuration, the system may perform 520 the configuration of the pump system.
The user may also enter 522 other types of input that the system may or may not recognize upon entry. For example, a database having various food values and their typical masses may be downloaded to the pump system. Here, the database can be used to compare typical “servings” of food items against what a user may consume. In this example, the database may be uploaded wirelessly from the Internet and may require further user interaction to appropriately store and use the database in the pump system. As such, an onboard assistance device may assist 524 the user in walking through configuration steps to ensure the database operates properly. The onboard assistance device may also intervene to assist the user for other unknown data entries.
FIG. 6 is a flow chart illustrating a method 600 of analyzing received criteria to determine or enhance a bolus amount in an infusion pump system.
The method 600 will be described in reference to an infusion pump system that analyzes user input to determine system parameter values, such as bolus amounts and rates. The method 600 may provide manual control of the infusion pump system by means of a device or program which assists the pump user with determining proper bolus amounts.
A healthy human body regulates insulin levels in the bloodstream using the pancreas organ. Insulin production relates closely to the rise of BG levels in the body (e.g., when glucose levels rise, insulin levels rise). A diabetic patient is unable to maintain consistent insulin levels and proper insulin response, and may require external means to assist in regulating their insulin levels. Insulin pump therapy may infuse insulin into fatty tissues just beneath the surface of the skin in a diabetic patient. This may create a delay in the absorption of insulin into the bloodstream.
Typically, insulin levels rise well after a rise in glucose level, thus, timing is a key issue in the delivery of insulin. This can make it difficult to adjust insulin levels in the body to an appropriate level. This may be compounded by the fact that most diabetics test their BG levels after they finish eating, sometimes significantly later than the start of the meal. Accordingly, external systems such as infusion pumps may be designed to account for time anomalies and the like when delivering medication to a pump user.
In addition, users may have different profiles as relate to digestion and metabolism. For example, a user may have different glucose sensitivity than other users, and be able to tolerate a higher or lower level of glucose. These particular individuals' metabolism may correlate to different glucose levels in the blood as a result of the same specific food intake. As another example, a user may have different insulin sensitivity in which the same amount of insulin will have a different effect on the Blood glucose level in the bloodstream. In addition, the metabolism time of glucose and insulin for one user may be faster or slower than for other users.
The method 600 begins when the infusion pump system receives 610 input from a pump user. For example, food on board (FOB) and insulin on board (IOB) values can be received in the pump system. FOB is a measurement of food previously consumed by a user. In one embodiment, FOB is a measurement of food that has been consumed by a user, but not yet converted into glucose usable by the body for metabolism. IOB is a measurement of the insulin previously dosed to a user. In one embodiment, IOB is a measure of the insulin that has been dosed to a user but not yet available for the metabolic process (i.e., insulin that has not yet been absorbed into the bloodstream). In another embodiment, IOB is a measure of the total insulin in a user's system, including insulin in the bloodstream or in the tissues. Thus, it may be a measure of all insulin that has not yet been metabolized.
In various embodiments, the system may use the FOB and IOB to calculate bolus amounts. Using more powerful microprocessors, pumps may be designed to determine and utilize information concerning the individual user. In various embodiments, individual parameters such as sensitivity to insulin, carbohydrates or other endocrine information may allow the pump to improve recommended treatments. In some implementations, the pump system may utilize food input and BG level input to accurately determine when a particular meal was started, when a peak glucose level will occur, and/or what an uncorrected BG level should be.
An onboard assistance system may include a processing method, for example, which incorporates carbohydrate, protein, and fat values to determine a value for food on board (“FOB”) for the user. The FOB calculation might correspond to the equivalent amount of carbohydrate for each of the protein and fat intakes. As such, the pump user may request a task, and be given further assistance by the onboard assistance system to carry out the task with accuracy.
The onboard assistance program may include a monitoring method that incorporates previously entered data and treatment information to determine a value for insulin on board (“IOB”) for the user. In general, an IOB feature in a pump calculates the decay of insulin in the body after a bolus of insulin is given to a pump user. The infusion pump system may recognize current dosage levels that a user is receiving and further, can measure the dosage to determine future infusion dosages or rates. The pump user can input several variables that the pump system can utilize to recommend one or more treatments. Advantageously, using an infusion pump having manual and autonomous control properties may allow an accurate estimate of a particular bolus rate or amount. In addition, the pump user may have flexibility in entering and modifying the bolus rate or amount at any time.
In one embodiment, a recommended bolus amount may be determined 620 using the following equation:
Recommended bolus amount=Food Now*Carb Ratio+(BG−BGtarget)*insulin sensitivity−IOB+FOB
where:
    • IOB f(t)*bolus
    • FOB=f(t)*grams Carb Ratio+f(t)*grams Protein Ratio+f(t)*grams Fat ratio
    • Food Now=the amount and type of foodstuffs ingested expressed in terms of grams, carbohydrates, proteins or fat.
The bolus amount determined by the above equation may be modified or enhanced 630 based on a BG correction factor. The BG correction factor may be calculated as the difference between the measured BG level and the target BG level. This difference, if any, may assist the pump user in determining if a midstream bolus correction factor is required or desired, as well as determine the potential magnitude of correction. In general, the measured BG level is a function of time against foodstuffs intake and calculated by the formula described above.
In some implementations, the BG correction factor may be determined by the maximum BG level whereby the maximum BG level is an individually determined number. The maximum BG level may be based on factors including prior history, experience, and desired treatment levels, and may be set by the user or a health care provider. The maximum BG level may be input and the bolus correction factor may then be calculated based on the maximum BG level. This may assist the pump user in determining if a midstream bolus correction factor may be required or desired, as well as determining the potential magnitude of correction.
In some implementations, the maximum allowable BG may be provided as input to the pump. In this example, the pump may analyze the input and suggest an appropriate bolus amount and corresponding timing. This information may also allow the pump to suggest 640 midstream corrective actions, such as a modification to an immediate or delayed bolus, additional BG checks or other recommended changes such as temporary suspension of therapy. If the infusion pump suggests a midstream bolus correction, a magnitude of correction can be determined 650 in the pump system. In one embodiment, the infusion pump may calculate a bolus amount based on information including the total intake of grams of carbohydrates, fat and protein, as well as the timing of the intake. A bolus amount may be recommended by calculating 620 system parameters. The outcome of the calculations may be made available 660 to the pump user in the user interface, for example.
In some implementations, a delayed bolus feature may be implemented to provide further precision in controlling a pump user's BG levels. For example, anticipating what a BG level may be after consumption of an entered foodstuff may allow the pump system to properly dose the pump user at an opportune time. In some implementations, the delayed bolus may be user selectable. For example, pump users may enter the time at which a particular foodstuff was consumed and set a time to receive a dose of insulin.
The modified treatment amount determined by the pump system may include the use of additional factors not normally used in infusion pump systems such as insulin pumps. The advantages of using additional information may include obtaining a treatment that is individually suited to the user, obtaining a treatment that has a better time profile to better match actual food consumption and medicament infusion, obtaining a treatment based on additional foodstuff information, or obtaining a treatment that is based in part on user metabolism. The additional information may be available due to increased processing and memory abilities, new ways of looking at ways to utilize information, and new methodologies to obtain information. For example, asking a user to enter a large amount of foodstuff information leads to low compliance. However, methods described herein enable easy entry of foodstuff information, resulting a better compliance and ability to utilize information.
FIG. 7 is a flow chart illustrating a method 700 of postponing disruptive alert messages in an infusion pump system.
The method 700 will be described in reference to an alert messaging system in an infusion pump. The alert messaging system may alert a pump user audibly, visually, or via another sense, such as a vibration (e.g., such that the user can feel an alarm is being generated). Visual indicators can include light emitting diodes (LEDs), touch screens, liquid crystal display (LCD) screens, or other visual devices. Audio indicators may include buzzer chips, piezoelectric indicators, or other technology, and the like. Thus, the alert messaging system can generate a disruptive alert to inform the user of an event.
In general, the alert messaging system may accept input from pump users, such as time, date and alarm or alert criteria. For example, the pump user may manually configure an alert-free period to suspend the receipt of the alerts for a set period of time (e.g. 4 hours). Alternatively, the pump user may manually request a suspension of the disruptive alerts until a certain specified time is reached (e.g. suspend until 6 am). As such, the pump may not produce or present audible, visual, or other disruptive alerts in that specified time period. In addition, the pump may be programmed to defer the alerts to either the resumption time or the end of time of the alert-free period.
The method 700 begins with the receipt 710 of a request for postponement of alert messages. For example, the pump user may enter a request for an alert-free period, or the system may activate a previously set alarm. Alert-free periods and alarms may be manually set by the pump user at any time. For example, preemptive alerts may be set in the pump system and may automatically engage at a set time.
When the alert postponement period begins, the infusion pump may disable 720 one or more indicators for the suspended alert. In some implementations, certain types of disruptive alerts may be suspended and replaced by other alert types. In one embodiment, the alert messaging system may replace audible or visual indicators with a vibration indicator, so that the pump will vibrate to provide an alert. As another example, a pump user may wish to suppress audio indicators for a long period of time, such as, during a seminar or meeting. Thus, the user may temporarily suspend audio alert indicators, but may still receive visual messaging and indicators.
In other implementations, all disruptive alerts may be suspended until a set time. The period of time may be determined by a requested period of time or may be determined by the period of time until the requested resumption time.
The method 700 may make inquiries over time to determine 730 whether or not the alert suppression time has expired. If the time has not completed, the suppression remains in progress and the system awaits expiration of the suppression time. If, however, the suppression time has expired, the alert indicators may be enabled 740 and the system may function accordingly. In addition to suspending alert messages, the pump system may also receive instructions to suspend other processes.
In some implementations, a health alert or alarm system may remain active even while the disruptive alert system has been disabled. Disruptive alerts generally relate to events, such as dispensing a bolus amount, a programmed change in infusion amounts, a reminder to check blood glucose levels, etc. Health alerts generally relate to health-critical events, which may have a significant health impact on the user if not addressed. Examples of events that may generate a health alerts include the container of medicine in the infusion pump reaching a low level, the container of medicine in the infusion pump being empty, a sensed blockage of flow from the infusion pump, or other events. As these events have a high priority, a health alert or alarm system may remain functional even during a requested alert suspension period.
As various pump devices may be bodily worn, and are typically very close to the user in many cases, the alert system used by the pump devices may be very disruptive and irritating. These disruptive alerts generally inform the user that a dosage has occurred, that a requested bolus was delivered, or other event. In many cases the user may already know that the event will be occurring. The advantages of disabling a disruptive alert system includes the advantages of turning off such alerts during meetings, during rest periods, or during periods requiring enhanced concentration. This enables the user (and others) to perform at an optimal level without distraction for a requested period. After the requested period, the pump system will automatically return to normal operation. Thus, no additional input or request is needed to return to normal operation. In addition, however, other types of alarms may be very important to the user, such as health alerts, that inform the user of a critical failure, problem, or other issue. These alarms may remain enabled even during the requested period for disabling disruptive alerts. This provides additional assurance and peace of mind to the user that critical alarms will not be missed.
FIG. 8 is a flow chart illustrating a method 800 of postponing medication dispersion in an infusion pump system.
The infusion pump may be equipped with a feature whereby the delivery of medication may be suspended temporarily at a specified time. The method 800 begins when the duration and time of suspension are entered 810 by the pump user, such as a patient or nurse, and the system can alert the user of the suspended status at a predetermined interval or period of time. The input can be manually entered into the infusion pump via a control center, graphical user interface, bar code reader, radio frequency (RF) reader, optical reader, infrared reader, wireless transmission via email or Internet, or other means suitable to enter data into a processing device.
Upon receiving a request to suspend medication, the system may disable 820 the medication delivery system. In some implementations, if suspended, the delivery of medication may be automatically or manually restarted after a predetermined period of time. In other implementations, the system may periodically assess 830 whether or not the entered suspension time has expired. If the suspension time has not expired, the system may continue to suspend medication and additional assessments may be performed in the future.
The medication delivery system may be enabled 840 for various reasons. In some implementations, expiration of the suspension time may invoke the pump system to enable the medication delivery system. In other implementations, a pump user may interrupt the medication delivery suspension to receive medications. For example, the pump user may be feeling symptoms that may require medication.
FIG. 9 is a flow chart illustrating a method 900 of transferring infusion pump parameters to one or more devices.
At various times, the pump system may need to be replaced to ensure proper treatment of the user. For example, over time, the components in a pump may wear out and require replacing. In one embodiment, the pump system may include a mechanism portion, and a control portion that may be communicably coupled and uncoupled when either portion is replaced. In some implementations, the mechanism portion may be detachable and disposable, while the control portion remains intact. For example, an old pump mechanism may be replaced by a new pump mechanism. In other implementations, the entire pump system may be a single unit, with non-detachable mechanism and control portions. In some embodiments, the mechanism and control portions may be integrated.
The method of autonomous control may be initiated for a new or previously unused pump by the transfer of parameters from a current pump system to initiate proper operation. The program and information may be the entire set of parameters including, but not limited to, bolus profile, basal rate, real time clock (“RTC”), blood glucose history, delivery history, and bolus history. The transfer of parameters may be accomplished by transfer from an active or previously programmed unit or a separate programming device to a new, unused or unprogrammed unit. Parameters can be transferred to the new pump by either wired or wireless communications.
The method 900 begins when the infusion pump system receives 910 a request to transfer parameters. In particular, a pump user may manually enter a request to upload or download pump operating parameters or feedback of suggested manual parameters to a database, another pump, the Internet, or various computer programs or computer files, to name a few examples. In some implementations, the data to be transferred can be stored internally or externally before a transfer is performed.
In some implementations, the method of autonomous control may be initiated for a new or previously unused pump by the automatic transfer of parameters by which the pump may initiate proper operation. Such operating parameters may include, but are not limited to, bolus profile, basal rate, RTC, BG history, delivery history, and bolus history. In one embodiment, the transfer of parameters may be accomplished by transfer from an active or previously programmed unit to a new, unused or unprogrammed unit. In another embodiment, the transfer of parameters may be downloaded to a database and uploaded to the unprogrammed unit at another time. Alternatively, a new or unprogrammed pump may have the program and information loaded from a separate programming device. The separate programming device may be connected to an external computer or device with an interface that may run on graphical user interface (GUI) standards associated with that computer.
In general, when a transfer is requested, the pump user may determine 920 a sending device from which the parameters and feedback will be transferred. In one embodiment, the sending device may be the current pump device. In other embodiments, the sending device may be a database, a digital computing device such as a laptop, desktop, workstation, personal digital assistant, server, or another device communicably coupled to the system.
After determining the sending device, the user may determine 930 the method of transfer. This transfer may be initiated by means of direct, pump-to-pump physical contact, an infrared port, wireless connection, or by method and means of a wired connection, such as through a USB port, a serial port, or other technologies. The information transferred may provide a seamless transition between the “old” pump (sending device) and the “new” pump. Using a wired connection to transfer the parameters may facilitate communication by way of acoustic, electromagnetic, optical or other form of signaling. Ideally, the connection may be made and the transfer of information may be completed before the use of the pump. The transfer of parameters can also be accomplished using wireless communication between the pumps. In general, the wireless transfer of parameters or files can be sent from the sending device to a receiving device (e.g., a new infusion pump) through a wireless connection, such as Bluetooth, Ethernet, or wireless Ethernet, to name a few examples.
In the event that the transfer determined between two infusion pumps, the receiving device may be configured 940 appropriately to receive data. For example, memory on the device may be erased or configured to receive an upload of data, or other parameters, such as alert systems and displays may be tested for proper functionality. In addition, the communication link may be tested 950 to ensure proper bandwidth or sufficiency of streaming. The communication link may fail prior to or concurrently with the initiation of the transfer. In this example, one or more configuration programs may be performed again, in an attempt to repair the link.
Once the configuration is complete and the data is ready for transfer, the parameters may be transferred 960 to the new pump. Upon completion of the transfer, the pump user may manually enable other systems on the new pump, install medication supplies, or enter further data. In some implementations, the pump system may indicate, visually or audibly, that further action is required from the pump user. In some implementations, the new pump system may perform a system check routine to ensure the pump will properly operate.
Direct communication from pump to pump enables a user to transfer operating history, user information, configuration parameters, and other information directly form one unit to another. The advantages of such an approach may include the ability to make such a transfer without requiring any additional equipment or setup. An approach that requires, for example, uploading and downloading from an internet site requires an internet connection, access to the specific site, and additional equipment. The user may not have all of these elements when a pump unit begins to fail. Thus, pump to pump direct transfer enables the information to be captured in a new pump unit rather than lost in cases where the website is down for maintenance, the internet connection is slow or non-existent, or the user is on vacation or other location where additional equipment may not be present. Direct communication from pump nit to pump unit also enables the use of disposable pump units, while still retaining information and history. For example, direct pump information transfer may transfer identification, configuration, and user information, resulting in an easy and direct initialization of a second pump unit. In addition, operating history, historical dosage and consumption information may be transferred directly to a new pump unit. Thus, the user may completely replace the equipment used, but have the full information available in the new unit. Such an approach is not useful, and in fact, cannot be done where a pump unit is “dumb”, and contains no processing or memory storage. Rather than using a separate control unit for all functions, and a pump unit for just dosing, a “smart” pump unit enables the use and transfer of information from the pump unit itself. Incorporating processing and memory capacity into the pump unit enables the use and transfer of additional information from one pump unit to another.
FIG. 10 is a flow chart illustrating a method 1000 for entering food data into an infusion pump to receive a treatment recommendation.
The method 1000 begins when personal user information is obtained 1010 from the user, or alternatively, accessed from the pump system. The pump user may manually enter personal information such as weight, medication ingested, exercise performed, or other health characteristics, and the system will store that data until needed in system analysis, for example. In some implementations, the personal user information can be used for analysis in determining recommended treatments or other suggestions for the pump user.
Next, the user may enter 1020 food information pertaining to food ingested for the day, or food about to be ingested. For example, the user may wish to know how much of a specific food item can be ingested without requiring medication. In another example, the user may simply wish to view statistics regarding prior consumption of the entered food.
In one example, the entered data may be analyzed, or compared 1030 with personal user information to determine proper bolus amounts and rates. For example, from the analyzed data, the system may internally determine the parameters for FOB and recommended bolus amount such as the example described in FIG. 3 above. In some implementations, the comparison 1030 may be performed to increase or decrease a medication dosage. For example, if the pump user has ingested a particularly high quantity of sugar filled food in one day, an analysis may be performed to determine whether or not to increase the insulin dosage.
Thus, user entered data may be used to determine 1040 any number of recommended treatments to benefit the health of the pump user. Recommended treatments may include medication dosages, consultant notices (e.g., consult a physician), technical support (e.g., to repair the pump for some reason), or simply recommendations on food consumption (e.g., dietary recommendations) and the like. Other treatment recommendations are possible in the system.
Some, all, or none of the determined treatments may be presented 1050 to the pump user in the user interface of the pump device. The pump user may accept, modify, or decline a proposed treatment. As such, treatment recommendations may typically await user feedback before carrying out the actual treatment. In some implementations, the recommended treatment may require a doctor's visit. In other implementations, the pump system may carry out the recommended treatment after the user accepts the treatment.
The user may also enter other types of input into the system. In one embodiment, device-assisted data entry may be used to enter foodstuff information. Typically, a user may be willing to enter carbohydrate information related to the food consumed. However, requesting additional information generally results in poor compliance. Using device-assisted data entry provides a method of obtaining additional foodstuff information that may be useful in determining recommended treatment amounts of a medicine or other material. Examples of device-assisted data entry include the use of barcode information, RFID tags, or food codes. The information may enter the pump system via various communication interfaces, such as those shown in the example embodiment of FIGS. 1-3.
In some embodiments, the data entered may include foodstuff information directly, such as amount of calories, carbohydrates, fats, and proteins. In most embodiments, however, the data entered may be used as a key or code by the system to obtain additional foodstuff information. For example, a database having various food values (including carbohydrate, fat, and protein content), and their typical amounts may be downloaded to the pump system. The database can be used to compare typical “servings” of food items against what a user may consume. The device-assisted data entry may enter a code value, which is then looked up in the database by the system to obtain various food values. The database may be provided as part of the pump system, may be uploaded wirelessly from the Internet, and/or may require further user interaction to appropriately store and use the database in the pump system. As such, an onboard assistance device may assist 524 the user in walking through configuration steps to ensure the database operates properly. The onboard assistance device may also intervene to assist the user for other unknown data entries.
The advantages of such an approach include the ability to utilize additional foodstuff information for the treatment of the user. Importantly, the additional foodstuff information may be obtained without requiring numerous additional steps or tasks by the user, and in same cases may require less input from a user. Thus, an approach that includes additional foodstuff information, enabling better treatment, may be easier for the user. As device assisted data entry may be easier, this approach may also increase user compliance with entering food and consumption information.
In some implementations, the methods 400-1000 may be performed by processing devices, such as those shown in FIG. 12 of this description. The processing devices may be located in a control unit, in the pump body, or in some combination thereof. In particular, when processing equipment is used by one of the above methods, the system may select one or more devices, from the system in FIG. 12 or another system, to perform the operations in the methods. In addition, the input received in the system, or as part of the above operations may be received in a user interface, such as through a touch screen, keyboard, or other manual entry device, a data collection device, such as can be connected to interfaces 212, 214, or 216.
Several systems may be used to carry out the operations in the methods described above. As such, FIG. 11 is simply one exemplary system for performing the operations in FIGS. 4-10. Accordingly, the above description of example embodiments does not define or constrain this disclosure to a particular system. Other changes, substitutions, and alterations are also possible without departing from the spirit and scope of this disclosure.
FIG. 11 is a block diagram illustrating an exemplary architecture 1100 for operating and controlling an infusion pump system. For example, the architecture 1100 may receive user instructions in one or more communication interfaces, such as the infrared port 212, USB port 214, RFID reader 216, or another attached interface, and may then implement the user instructions accordingly. In some implementations, the architecture may respond to user instructions or requests with inquiries about the user entered instructions. For example, if a foodstuff is received via the RFID reader 216, the architecture 1100 may respond to request a particular mass for the entered foodstuff.
The architecture 1100 includes a control unit 1102 and a pump unit 1104 that may be communicably coupled through interface 1106. The interface 1106 facilitates wireless, wired, contact, near proximity, or contactless communication between the control unit 1102 and the pump unit 1104. While illustrated as a single or continuous interface, the interface 1106 may be logically divided into individual interfaces on either unit 1102 or 1104 without departing from the scope of this disclosure, so long as at least a portion of the interface 1106 may facilitate communications between the control unit 1102 and the pump unit 1104.
The control unit 1102 may include various modules to perform functions in the pump system. The modules may include a user interface module 1108, a user assistance module 1110, a configuration module 1112, a control communication module 1114, and a processing module 1115. The modules may interact with the pump user, the pump unit 1104, and other system components, as necessary to carry out system tasks. For example, the modules may control the dispensing of medication by controlling the reservoir 105. The modules may be stored in a nonvolatile storage location, such as data repository 1116 or another repository in the system, and may be transferred to memory 1116 for active use by the architecture 1100.
The user interface module 1108 may provide the user with a mechanism to input data into the pump system. Here, the user interface module 1108 may also display system information to the pump user, such as BG history or recommended bolus information, for example.
The user assistance module 1110 may provide guidance and recommendations to the user when a system function is scheduled, or when the user has requested a system modification. In some implementations, the user assistance module 1110 may provide suggestions and calculation values to assist the user in determining a course of action for the pump system.
The configuration module 1112 may configure the pump system upon user request. For example, pump components, such as the drive mechanism 202 can be configured to the pump system parameters upon receiving a request from the pump user. In addition, the configuration module 1112 may configure a new pump upon installation. In general, the configuration module 1112 may be user controlled, and thus, may not have prior system settings. For example, pump users may input personal information to “calibrate” the configuration module 1112 to appropriate settings.
The control communication module 1114 may receive user information via the user interface module 1108, a barcode reader, an RF reader, a PDA, a cell phone, or other such technology, and transfer the data to the pump unit 1104. For example, the control communication module 1114 may transfer user entered data, calculation data, modification data, operating instructions, and the like to the pump unit 1104. The pump unit 1104 may then carry out any instructions, or user modifications that the control unit 1102 deemed necessary.
The processing module 1115 may include one or more processors to execute instructions and manipulate data for performing the operations of the control unit 1104. The processing module 1115 may include a central processing unit (CPU), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or other suitable hardware or software control system, for example.
The control unit 1102 may include local electronic storage capacity, such as data repository 1116. The data repository 1116 may include any memory or database module and may take the form of volatile or non-volatile memory including, without limitation, magnetic media, optical media, random access memory (RAM), read-only memory (ROM), removable media, or any other suitable local or remote memory component. The illustrated data repository 1116 may store system data, such as alert data, food data, medication data, reporting files, system parameters, user entered data, and others.
The pump unit 1104 may include a pump communication module 1118, pump controls 1120, and a pump mechanism 1122. In general, the pump communication module 1118 may receive instructions from the control communication module 1114. Specifically, user instructions or requests may be entered into the user interface module 1108 of the control unit 1102, whereby, the control communication module 1114 may transfer the instructions or requests into the pump communication module 1118. The module 1118 may then provide the information to the pump controls 1120 which may translate the instructions for the pump mechanism 1122.
The pump controls 1120 may include one or more processors to execute instructions and manipulate data for performing the operations of the pump unit 1104. The pump controls 1120 may include, for example, CPUs, ASICs, FPGAs, or other suitable hardware or software control system. In the illustrated implementation, the pump controls 1120 translate instructions for the pump mechanism 1122. The pump mechanism 1122 may deliver medication dosages to the pump user. For example, the pump mechanism 1122 can deliver a medication such as insulin in a basal dose, or a bolus dose to correct BG levels in the pump user's body.
In some implementations, the control unit 1102 may be included as a portion of the pump unit 1104. In other implementations, the control unit 1102 may be a separate, detachable entity from the pump unit 1104. Regardless of whether or not the control unit 1102 and the pump unit 1104 are separate entities, in operation, system processing may occur in the control unit 1102, in the pump unit 1104, or may occur in a combination of both.
FIG. 12 is a schematic diagram of an example of a generic infusion pump computing system 1200. The system 1200 can be used for the operations described in association with the methods in this disclosure according to one implementation. For example, the system 1200 may be included in any or all of the computing system 800, the pumps 900, 1000 or 1100.
The system 1200 includes a processor 1210, a memory 1220, a storage device 1230, and an input/output device 1240. Each of the components 1210, 1220, 1230, and 1240 are interconnected using a system bus 1250. The processor 1210 is capable of processing instructions for execution within the system 1200. In one implementation, the processor 1210 is a single-threaded processor. In another implementation, the processor 1210 is a multi-threaded processor. The processor 1210 is capable of processing instructions stored in the memory 1220 or on the storage device 1230 to display graphical information for a user interface on the input/output device 1240. The processors shown in FIG. 12 may be included in some, all, or none of the modules shown in FIG. 11. The processors and modules may be located within a pump body (such as the example pump body shown in FIGS. 1-3), or may be located within a control unit. In some embodiments, the control unit may be detachable from the pump body. In some embodiments, some of the modules or processors may be located in a control unit, while others are located within a pump body.
The memory 1220 stores information within the system 1200. In one implementation, the memory 1220 is a computer-readable medium. In one implementation, the memory 1220 is a volatile memory unit. In another implementation, the memory 1220 is a non-volatile memory unit.
The storage device 1230 is capable of providing mass storage for the system 1200. In one implementation, the storage device 1230 is a computer-readable medium. In various different implementations, the storage device 1230 may be a floppy disk device, a hard disk device, an optical disk device, or a tape device.
The input/output device 1240 provides input/output operations for the system 1200. In one implementation, the input/output device 1240 includes a keyboard and/or pointing device. In another implementation, the input/output device 1240 includes a display unit for displaying graphical user interfaces.
The features described can be implemented in digital electronic circuitry, or in computer hardware, firmware, software, or in combinations of them. The apparatus can be implemented in a computer program product tangibly embodied in an information carrier, e.g., in a machine-readable storage device or in a propagated signal, for execution by a programmable processor; and method steps can be performed by a programmable processor executing a program of instructions to perform functions of the described implementations by operating on input data and generating output. The described features can be implemented advantageously in one or more computer programs that are executable on a programmable system including at least one programmable processor coupled to receive data and instructions from, and to transmit data and instructions to, a data storage system, at least one input device, and at least one output device. A computer program is a set of instructions that can be used, directly or indirectly, in a computer to perform a certain activity or bring about a certain result. A computer program can be written in any form of programming language, including compiled or interpreted languages, and it can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment.
Suitable processors for the execution of a program of instructions include, by way of example, both general and special purpose microprocessors, and the sole processor or one of multiple processors of any kind of computer. Generally, a processor will receive instructions and data from a read-only memory or a random access memory or both. The essential elements of a computer are a processor for executing instructions and one or more memories for storing instructions and data. Generally, a computing system will also include, or be operatively coupled to communicate with, one or more mass storage devices for storing data files; such devices include magnetic disks, such as internal hard disks and removable disks; magneto-optical disks; and optical disks. Storage devices suitable for tangibly embodying computer program instructions and data include all forms of non-volatile memory, including by way of example semiconductor memory devices, such as EPROM, EEPROM, and flash memory devices; magnetic disks such as internal hard disks and removable disks; magneto-optical disks; and CD-ROM and DVD-ROM disks. The processor and the memory can be supplemented by, or incorporated in, ASICs (application-specific integrated circuits).
To provide for interaction with a user, the features can be implemented on a computing device or infusion pump device having a display device an LCD (liquid crystal display) monitor for displaying information to the user and a keyboard, keypad, or pointing device by which the user can provide input to the computer.
In addition, the logic flows depicted in the figures do not require the particular order shown, or sequential order, to achieve desirable results. In addition, other steps may be provided, or steps may be eliminated, from the described flows, and other components may be added to, or removed from, the described systems. Accordingly, other implementations are within the scope of the following claims.
While this specification contains many specifics, these should not be construed as limitations on the scope of the invention or of what may be claimed, but rather as descriptions of features specific to particular embodiments of the invention. Certain features that are described in this specification in the context of separate embodiments can also be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment can also be implemented in multiple embodiments separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations, one or more features from a claimed combination can in some cases be excised from the combination.
Similarly, while operations are depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results. In certain circumstances, multitasking and parallel processing may be advantageous. Moreover, the separation of various system components in the embodiments described above should not be understood as requiring such separation in all embodiments, and it should be understood that the described program components and systems can generally be integrated together in a single software product or packaged into multiple software products.
Although the present invention has been described with reference to specific embodiments, these embodiments are illustrative only and not limiting. Many other applications and embodiments of the present invention will be apparent in light of this disclosure and the following claims.

Claims (25)

1. A method for temporarily disabling a disruptive alert of a portable infusion pump system, comprising:
receiving a request via a user interface of a portable infusion pump system to disable disruptive alerts from the portable infusion pump system for a specified period of time, the user interface being coupled to a control unit of the portable infusion pump system that controls the dispensation of medicine from a pump unit;
disabling disruptive alerts from the portable infusion pump system for the specified period of time;
during the specified period in which the disruptive alerts are disabled, outputting an alarm from the portable infusion pump system indicative of a sensed blockage of flow from the portable infusion pump system; and
re-enabling disruptive alerts after the specified period of time has passed.
2. The method of claim 1, wherein the specified period of time is determined by the difference between the current time and a requested time.
3. The method of claim 1, wherein the specified time is determined by a request for a specified time period.
4. The method of claim 1, wherein health alerts remain active during the specified period of time.
5. The method of claim 4, wherein the heath alerts relate to health-critical events including a container of medicine in the portable infusion pump being empty and the sensed blockage of flow from the portable infusion pump.
6. The method of claim 5, wherein the disruptive alerts relate to a different event selected from the group consisting of a dispensation of a bolus amount, a programmed change in infusion amounts, and a reminder to check blood glucose levels.
7. The method of claim 1, wherein the disruptive alerts comprise audio indicators from the infusion pump system.
8. The method of claim 1, wherein the disruptive alerts comprise visual indicators displayed via a display screen of the infusion pump system.
9. The method of claim 1, wherein the disruptive alerts comprise vibration indicators from the infusion pump system.
10. The method of claim 1, wherein the step of disabling disruptive alerts from the infusion pump system for the specified period of time comprises disabling a first type of disruptive alerts indicative of a first condition for replacement by a second type of alerts indicative of the same first condition.
11. The method of claim 10, wherein the first type of disruptive alerts comprises audible or visual indicators, and the second type of alert comprises a vibration indicator so that the infusion pump system vibrates to provide an alert in lieu of providing an audible indicator for the specified period of time.
12. The method of claim 1, wherein the step of receiving a request to disable disruptive alerts comprises receiving user input via a user interface module to establish an alert-free period that suspends the output of disruptive alerts for the specified period of time determined by the difference between the current time and a requested time.
13. The method of claim 1, wherein the step of receiving a request to disable disruptive alerts comprises receiving user input via a user interface module to establish an alert-free period that suspends the output of disruptive alerts until a user-selected time of day.
14. The method of claim 1, wherein the step of re-enabling disruptive alerts after the specified period of time has passed comprises automatically returning, without any additional user input or requests, to a normal operational mode in which disruptive alerts are unsuspended.
15. The method of claim 1, further comprising temporarily suspending the delivery of medication from the infusion pump system for a selected period of time in response to user input on a graphical user interface.
16. A method for temporarily disabling a disruptive alert of an infusion pump system, comprising:
receiving a request to disable disruptive alerts from an infusion pump system for a specified period of time, wherein the infusion pump system comprises a control unit having a user interface module and a pump unit having a pump mechanism, wherein the control unit communicates with the pump unit via a wireless interface;
disabling disruptive alerts from the infusion pump system for the specified period of time, wherein health alerts remain active during the specified period of time, wherein the heath alerts relate to a health-critical event selected from the group consisting of a container of medicine in the infusion pump being empty and a sensed blockage of flow from the infusion pump, and wherein the disruptive alerts relate to a different event selected from the group consisting of a dispensation of a bolus amount, a programmed change in infusion amounts, and a reminder to check blood glucose levels; and
re-enabling disruptive alerts after the specified period of time has passed.
17. The method of claim 1, wherein the infusion pump system comprises a control unit having a user interface module and a pump unit having a pump mechanism and a medicine reservoir, wherein the control unit communicates with the pump unit via an electrical connection between the control unit and the pump unit.
18. The method of claim 16, wherein the specified period of time is determined by the difference between the current time and a requested time.
19. The method of claim 16, wherein the specified time is determined by a request for a specified time period.
20. The method of claim 16, wherein the heath alerts relate to sensed blockage of flow from the infusion pump.
21. A portable infusion pump system comprising a pump unit, and a control unit that controls the dispensation of medicine from the pump unit, and a user interface coupled to the control unit of the portable infusion pump system that controls the dispensation of medicine from the pump unit, wherein the control unit is programmed to:
receive a request via the user interface of the portable infusion pump system to disable disruptive alerts from the portable infusion pump system for a specified period of time;
disable disruptive alerts from the portable infusion pump system for the specified period of time;
during the specified period in which the disruptive alerts are disabled, output an alarm from the portable infusion pump system indicative of a sensed blockage of flow from the portable infusion pump system; and
re-enable disruptive alerts after the specified period of time has passed.
22. The system of claim 21, wherein the control unit is programmed to disable the disruptive alerts for the specified period of time while health alerts from the portable infusion pump system remain active during the specified period of time.
23. The system of claim 22, wherein the heath alerts relate to health-critical events including a container of medicine in the portable infusion pump being empty and the sensed blockage of flow from the portable infusion pump.
24. The system of claim 23, wherein the disruptive alerts relate to a different event selected from the group consisting of a dispensation of a bolus amount, a programmed change in infusion amounts, and a reminder to check blood glucose levels.
25. The system of claim 21, wherein the control unit is programmed to re-enable disruptive alerts after the specified period of time has passed by automatically returning, without any additional user input or requests, to a normal operational mode in which disruptive alerts are unsuspended.
US11/557,926 2005-11-08 2006-11-08 Method and system for manual and autonomous control of an infusion pump Active 2031-04-06 US8192394B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/557,926 US8192394B2 (en) 2005-11-08 2006-11-08 Method and system for manual and autonomous control of an infusion pump
US13/468,669 US20120220940A1 (en) 2005-11-08 2012-05-10 Method and System for Manual and Autonomous Control of an Infusion Pump
US13/489,603 US9205192B2 (en) 2005-11-08 2012-06-06 Method and system for manual and autonomous control of an infusion pump
US13/490,602 US9114209B2 (en) 2005-11-08 2012-06-07 Method and system for manual and autonomous control of an infusion pump
US13/491,828 US20120245524A1 (en) 2005-11-08 2012-06-08 Method and System for Manual and Autonomous Control of an Infusion Pump

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73439805P 2005-11-08 2005-11-08
US11/557,926 US8192394B2 (en) 2005-11-08 2006-11-08 Method and system for manual and autonomous control of an infusion pump

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/468,669 Division US20120220940A1 (en) 2005-11-08 2012-05-10 Method and System for Manual and Autonomous Control of an Infusion Pump

Publications (2)

Publication Number Publication Date
US20070124002A1 US20070124002A1 (en) 2007-05-31
US8192394B2 true US8192394B2 (en) 2012-06-05

Family

ID=37835238

Family Applications (5)

Application Number Title Priority Date Filing Date
US11/557,926 Active 2031-04-06 US8192394B2 (en) 2005-11-08 2006-11-08 Method and system for manual and autonomous control of an infusion pump
US13/468,669 Abandoned US20120220940A1 (en) 2005-11-08 2012-05-10 Method and System for Manual and Autonomous Control of an Infusion Pump
US13/489,603 Active 2028-01-04 US9205192B2 (en) 2005-11-08 2012-06-06 Method and system for manual and autonomous control of an infusion pump
US13/490,602 Active 2027-02-08 US9114209B2 (en) 2005-11-08 2012-06-07 Method and system for manual and autonomous control of an infusion pump
US13/491,828 Abandoned US20120245524A1 (en) 2005-11-08 2012-06-08 Method and System for Manual and Autonomous Control of an Infusion Pump

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/468,669 Abandoned US20120220940A1 (en) 2005-11-08 2012-05-10 Method and System for Manual and Autonomous Control of an Infusion Pump
US13/489,603 Active 2028-01-04 US9205192B2 (en) 2005-11-08 2012-06-06 Method and system for manual and autonomous control of an infusion pump
US13/490,602 Active 2027-02-08 US9114209B2 (en) 2005-11-08 2012-06-07 Method and system for manual and autonomous control of an infusion pump
US13/491,828 Abandoned US20120245524A1 (en) 2005-11-08 2012-06-08 Method and System for Manual and Autonomous Control of an Infusion Pump

Country Status (3)

Country Link
US (5) US8192394B2 (en)
EP (2) EP1955240B8 (en)
WO (1) WO2007056592A2 (en)

Cited By (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050143864A1 (en) * 2002-02-28 2005-06-30 Blomquist Michael L. Programmable insulin pump
US20070203872A1 (en) * 2003-11-28 2007-08-30 Manyworlds, Inc. Affinity Propagation in Adaptive Network-Based Systems
US20080021436A1 (en) * 1998-04-30 2008-01-24 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US20090163789A1 (en) * 1998-04-30 2009-06-25 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20100094110A1 (en) * 1998-04-30 2010-04-15 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20110238032A1 (en) * 2010-03-24 2011-09-29 Baxter International Inc. Multiple drug infusion system and method
US20120265722A1 (en) * 2007-05-24 2012-10-18 Michael Blomquist Expert system for insulin pump therapy
US8333716B1 (en) 2011-06-21 2012-12-18 Yofimeter, Llc Methods for using an analyte testing device
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US8512246B2 (en) 2003-04-28 2013-08-20 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8571808B2 (en) 2007-05-14 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US8612163B2 (en) 2007-05-14 2013-12-17 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8638220B2 (en) 2005-10-31 2014-01-28 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US8653977B2 (en) 2005-05-17 2014-02-18 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8682615B2 (en) 2007-05-14 2014-03-25 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8718949B2 (en) 2008-01-07 2014-05-06 Tandem Diabetes Care, Inc. Insulin pump with blood glucose modules
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8753316B2 (en) 2006-10-17 2014-06-17 Tandem Diabetes Care, Inc. Insulin pump for determining carbohydrate consumption
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US8795252B2 (en) 2008-08-31 2014-08-05 Abbott Diabetes Care Inc. Robust closed loop control and methods
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US8840582B2 (en) 2008-01-09 2014-09-23 Tandem Diabetes Care, Inc. Infusion pump with activity monitoring
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8961432B2 (en) 2011-06-21 2015-02-24 Yofimeter, Llc Analyte testing devices
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9031630B2 (en) 2006-02-28 2015-05-12 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9295778B2 (en) 2011-12-21 2016-03-29 Deka Products Limited Partnership Syringe pump
US9320468B2 (en) 2008-01-31 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9326727B2 (en) 2006-01-30 2016-05-03 Abbott Diabetes Care Inc. On-body medical device securement
US9332934B2 (en) 2007-10-23 2016-05-10 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US9357959B2 (en) 2006-10-02 2016-06-07 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US9408566B2 (en) 2006-08-09 2016-08-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9439586B2 (en) 2007-10-23 2016-09-13 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US9483608B2 (en) 2007-05-14 2016-11-01 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9541556B2 (en) 2008-05-30 2017-01-10 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9558325B2 (en) 2007-05-14 2017-01-31 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9649439B2 (en) 2005-08-31 2017-05-16 Michael Sasha John Systems and methods for facilitating patient-based adjustment of drug infusion
US9669160B2 (en) 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
US9675756B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership Apparatus for infusing fluid
US9677555B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US9721063B2 (en) 2011-11-23 2017-08-01 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9730623B2 (en) 2008-03-28 2017-08-15 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9737656B2 (en) 2013-12-26 2017-08-22 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9744300B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Syringe pump and related method
US9782076B2 (en) 2006-02-28 2017-10-10 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US9789247B2 (en) 2011-12-21 2017-10-17 Deka Products Limited Partnership Syringe pump, and related method and system
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9814416B2 (en) 2009-08-31 2017-11-14 Abbott Diabetes Care Inc. Displays for a medical device
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US9913600B2 (en) 2007-06-29 2018-03-13 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US9931075B2 (en) 2008-05-30 2018-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10009244B2 (en) 2009-04-15 2018-06-26 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10082493B2 (en) 2011-11-25 2018-09-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US10111608B2 (en) 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10173007B2 (en) 2007-10-23 2019-01-08 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US10194844B2 (en) 2009-04-29 2019-02-05 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US10206629B2 (en) 2006-08-07 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US10242159B2 (en) 2010-01-22 2019-03-26 Deka Products Limited Partnership System and apparatus for electronic patient care
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US10265463B2 (en) 2014-09-18 2019-04-23 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US10328201B2 (en) 2008-07-14 2019-06-25 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
EP3383456A4 (en) * 2015-12-03 2019-08-21 UNL Holdings LLC Systems and methods for controlled drug delivery pumps
US10391241B2 (en) 2010-01-22 2019-08-27 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US20190341137A1 (en) * 2018-05-07 2019-11-07 Medtronic Minimed, Inc. Proactive image-based infusion device delivery adjustments
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10653834B2 (en) 2012-06-07 2020-05-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US10685749B2 (en) 2007-12-19 2020-06-16 Abbott Diabetes Care Inc. Insulin delivery apparatuses capable of bluetooth data transmission
US10722645B2 (en) 2011-12-21 2020-07-28 Deka Products Limited Partnership Syringe pump, and related method and system
US10857287B2 (en) 2017-01-06 2020-12-08 Trustees Of Boston University Infusion system and components thereof
US10872685B2 (en) 2010-01-22 2020-12-22 Deka Products Limited Partnership Electronic patient monitoring system
US10881789B2 (en) 2013-10-24 2021-01-05 Trustees Of Boston University Infusion system for preventing mischanneling of multiple medicaments
US10911515B2 (en) 2012-05-24 2021-02-02 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US10967119B1 (en) 2019-04-01 2021-04-06 Azizi Bilal Wearable medication injecting device
US11135363B2 (en) 2019-07-16 2021-10-05 Beta Bionics, Inc. Ambulatory medicament device alarm system
US11164672B2 (en) 2010-01-22 2021-11-02 Deka Products Limited Partnership System and apparatus for electronic patient care
US11210611B2 (en) 2011-12-21 2021-12-28 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US11217340B2 (en) 2011-12-21 2022-01-04 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
US11295846B2 (en) 2011-12-21 2022-04-05 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11331463B2 (en) 2015-07-08 2022-05-17 Trustees Of Boston University Infusion system and components thereof
US11484644B2 (en) 2011-09-13 2022-11-01 Unl Holdings Llc Sterile fluid pathway connection to drug containers for drug delivery pumps
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11497849B2 (en) 2020-12-07 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11571507B2 (en) 2019-07-16 2023-02-07 Beta Bionics, Inc. Ambulatory device and components thereof
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11707615B2 (en) 2018-08-16 2023-07-25 Deka Products Limited Partnership Medical pump
US11872368B2 (en) 2018-04-10 2024-01-16 Tandem Diabetes Care, Inc. System and method for inductively charging a medical device
US11881307B2 (en) 2012-05-24 2024-01-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care

Families Citing this family (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009160A1 (en) 2002-07-24 2004-01-29 M 2 Medical A/S An infusion pump system, an infusion pump unit and an infusion pump
US20050160858A1 (en) * 2002-07-24 2005-07-28 M 2 Medical A/S Shape memory alloy actuator
EP1560616B1 (en) 2002-11-05 2018-01-24 Bigfoot Biomedical, Inc. A disposable wearable insulin dispensing device, a combination of such a device and a programming controller
CN1738656A (en) 2002-12-23 2006-02-22 M2医药有限公司 Disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
DE60336080D1 (en) * 2002-12-23 2011-03-31 Asante Solutions Inc BENDING PISTON ROD
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7753879B2 (en) * 2004-01-29 2010-07-13 M2 Group Holdings, Inc. Disposable medicine dispensing device
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
CA2572455C (en) 2004-06-04 2014-10-28 Therasense, Inc. Diabetes care host-client architecture and data management system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
WO2006105793A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S Method and device for dispensing liquid medicine by means of a twistable element
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
EP1921980A4 (en) 2005-08-31 2010-03-10 Univ Virginia Improving the accuracy of continuous glucose sensors
ES2354107T3 (en) 2005-09-12 2011-03-10 Unomedical A/S INSERTION DEVICE FOR AN INFUSION TEAM WITH A FIRST AND SECOND SPRING UNITS.
US7534226B2 (en) 2005-09-26 2009-05-19 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8105279B2 (en) 2005-09-26 2012-01-31 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US7794427B2 (en) * 2005-09-26 2010-09-14 Asante Solutions, Inc. Operating an infusion pump system
US8409142B2 (en) 2005-09-26 2013-04-02 Asante Solutions, Inc. Operating an infusion pump system
US8551046B2 (en) 2006-09-18 2013-10-08 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US8057436B2 (en) * 2005-09-26 2011-11-15 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
DE602006008494D1 (en) 2005-11-08 2009-09-24 M2 Medical As INFUSION PUMP SYSTEM
EP1955240B8 (en) 2005-11-08 2016-03-30 Bigfoot Biomedical, Inc. Method for manual and autonomous control of an infusion pump
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7706896B2 (en) * 2006-09-29 2010-04-27 Nellcor Puritan Bennett Llc User interface and identification in a medical device system and method
MX2009004530A (en) 2006-10-26 2009-08-13 Abbott Diabetes Care Inc Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors.
US7734323B2 (en) * 2007-01-24 2010-06-08 Smiths Medical Asd, Inc. Correction factor testing using frequent blood glucose input
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
EP2137637A4 (en) 2007-04-14 2012-06-20 Abbott Diabetes Care Inc Method and apparatus for providing data processing and control in medical communication system
EP2146622B1 (en) 2007-04-14 2016-05-11 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7981102B2 (en) 2007-05-21 2011-07-19 Asante Solutions, Inc. Removable controller for an infusion pump
US7833196B2 (en) 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
US7892199B2 (en) 2007-05-21 2011-02-22 Asante Solutions, Inc. Occlusion sensing for an infusion pump
US7794426B2 (en) 2007-05-21 2010-09-14 Asante Solutions, Inc. Infusion pump system with contamination-resistant features
WO2008157820A1 (en) 2007-06-21 2008-12-24 Abbott Diabetes Care, Inc. Health management devices and methods
ES2767265T3 (en) * 2007-06-21 2020-06-17 Hoffmann La Roche Device and procedure to prevent hypoglycemia
AU2008265542B2 (en) 2007-06-21 2014-07-24 Abbott Diabetes Care Inc. Health monitor
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7828528B2 (en) * 2007-09-06 2010-11-09 Asante Solutions, Inc. Occlusion sensing system for infusion pumps
US7935076B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Activity sensing techniques for an infusion pump system
US7879026B2 (en) 2007-09-07 2011-02-01 Asante Solutions, Inc. Controlled adjustment of medicine dispensation from an infusion pump device
US8032226B2 (en) * 2007-09-07 2011-10-04 Asante Solutions, Inc. User profile backup system for an infusion pump device
US8287514B2 (en) 2007-09-07 2012-10-16 Asante Solutions, Inc. Power management techniques for an infusion pump system
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
EP2060289A1 (en) * 2007-11-13 2009-05-20 F.Hoffmann-La Roche Ag Administration device comprising indication unit and method for setting a dose
US7875022B2 (en) 2007-12-12 2011-01-25 Asante Solutions, Inc. Portable infusion pump and media player
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8234126B1 (en) 2008-02-12 2012-07-31 Asante Solutions, Inc. Distribution of infusion pumps
EP2093685A1 (en) 2008-02-21 2009-08-26 F.Hoffmann-La Roche Ag Drug administration device having a bolus administration profile controller
DK2252956T3 (en) * 2008-03-03 2019-03-25 Hoffmann La Roche INSULIN PUMP WITH REPLACEMENT OPPORTUNITIES
ES2787230T3 (en) * 2008-05-29 2020-10-15 Hoffmann La Roche Modular medical infusion device with means for identification / authentication between its components
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
EP2315549A2 (en) * 2008-07-18 2011-05-04 Lifescan, Inc. Analyte measurement and management device and associated methods
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
DK2164013T3 (en) 2008-09-02 2017-06-06 Hoffmann La Roche Method and apparatus for setting a base rate profile for an insulin pump
US8452953B2 (en) * 2008-09-05 2013-05-28 Roche Diagnostics Operations, Inc. Insulin pump programming software for selectively modifying configuration data
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
WO2010033878A2 (en) 2008-09-19 2010-03-25 David Brown Solute concentration measurement device and related methods
US8287487B2 (en) * 2008-10-15 2012-10-16 Asante Solutions, Inc. Infusion pump system and methods
US9149220B2 (en) 2011-04-15 2015-10-06 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
WO2010068783A1 (en) * 2008-12-12 2010-06-17 Corindus Inc. Remote catheter procedure system
ES2937657T3 (en) * 2008-12-19 2023-03-30 Hoffmann La Roche Portable drug delivery device switchable between two different delivery modes
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
EP2419015A4 (en) 2009-04-16 2014-08-20 Abbott Diabetes Care Inc Analyte sensor calibration management
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
AU2010286917B2 (en) 2009-08-31 2016-03-10 Abbott Diabetes Care Inc. Medical devices and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
EP2338552B1 (en) * 2009-12-28 2017-07-19 F. Hoffmann-La Roche AG Ambulatory infusion device with bolus administration delay
EP2531232B1 (en) * 2010-02-05 2016-10-19 DEKA Products Limited Partnership Infusion pump apparatus and heated fill adapter system
WO2011112753A1 (en) 2010-03-10 2011-09-15 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
BR112012024635A2 (en) 2010-03-30 2017-08-08 Unomedical As medical device
USD669165S1 (en) 2010-05-27 2012-10-16 Asante Solutions, Inc. Infusion pump
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
WO2012012552A1 (en) * 2010-07-22 2012-01-26 Thoratec Corporation Controlling implanted blood pumps
US8984194B2 (en) 2011-01-21 2015-03-17 Numia Medical Technology Llc Multi-master bus arbitration and resource control
US8852152B2 (en) 2011-02-09 2014-10-07 Asante Solutions, Inc. Infusion pump systems and methods
EP3583901A3 (en) 2011-02-28 2020-01-15 Abbott Diabetes Care, Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10194938B2 (en) 2011-03-14 2019-02-05 UnoMedical, AS Inserter system with transport protection
US8308680B1 (en) * 2011-04-26 2012-11-13 Medtronic Minimed, Inc. Selective alarms for an infusion device
US8585657B2 (en) 2011-06-21 2013-11-19 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US8808230B2 (en) 2011-09-07 2014-08-19 Asante Solutions, Inc. Occlusion detection for an infusion pump system
EP2763723B1 (en) 2011-10-05 2016-04-13 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
AU2012335830B2 (en) 2011-11-07 2017-05-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US20140336615A1 (en) * 2011-12-02 2014-11-13 Bayer Medical Care Inc. Systems And Methods For Injecting Cellular Fluids
EP3682871A1 (en) * 2012-03-05 2020-07-22 Becton, Dickinson and Company Apparatus for adhesive removal
US8454557B1 (en) 2012-07-19 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US8454562B1 (en) 2012-07-20 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US20140095181A1 (en) * 2012-09-28 2014-04-03 General Electric Company Methods and systems for managing performance based sleep patient care protocols
US9427523B2 (en) 2012-12-10 2016-08-30 Bigfoot Biomedical, Inc. Infusion pump system and method
US20140276536A1 (en) 2013-03-14 2014-09-18 Asante Solutions, Inc. Infusion Pump System and Methods
MX354897B (en) * 2013-02-08 2018-03-23 Baxter Corp Englewood Code for patient care device configuration.
US9446186B2 (en) 2013-03-01 2016-09-20 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US9446187B2 (en) 2013-06-03 2016-09-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US9457141B2 (en) 2013-06-03 2016-10-04 Bigfoot Biomedical, Inc. Infusion pump system and method
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
RU2683203C2 (en) 2013-12-31 2019-03-26 Эбботт Дайабитиз Кэр Инк. Self-powered analyte sensor and devices using the same
DE102014003249A1 (en) * 2014-03-12 2015-09-17 Wilo Se Method for configuring an electromotive pump set
EP4151150A1 (en) 2014-03-30 2023-03-22 Abbott Diabetes Care, Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US9629901B2 (en) 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US11464899B2 (en) 2014-08-28 2022-10-11 Becton, Dickinson And Company Wireless communication for on-body medical devices
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
JP2018524718A (en) 2015-06-25 2018-08-30 ガンブロ・ルンディア・エービーGambro Lundia Ab Medical device system and method with distributed database
KR20180081515A (en) 2015-11-12 2018-07-16 아벤트, 인크. Patient Results Tracking Platform
US10417389B2 (en) * 2015-12-04 2019-09-17 Zyno Medical, Llc Application development system for medical pumps
WO2017114949A1 (en) * 2015-12-31 2017-07-06 Koninklijke Philips N.V. Automatically communicating between a non-mri compatible iv pump and a mri compatible iv pump
CA3009409A1 (en) 2016-01-05 2017-07-13 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
CN108778370B (en) 2016-01-19 2021-10-08 优诺医疗有限公司 Cannula and infusion device
USD809134S1 (en) 2016-03-10 2018-01-30 Bigfoot Biomedical, Inc. Infusion pump assembly
WO2018022355A1 (en) * 2016-07-25 2018-02-01 Smiths Medical Asd, Inc. Cloning medical device configurations
CA3036266A1 (en) 2016-09-27 2018-04-05 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
AU2017381172A1 (en) 2016-12-21 2019-06-13 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
EP3651647A1 (en) 2017-07-13 2020-05-20 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
CN107890594A (en) * 2017-10-11 2018-04-10 江苏人先医疗科技有限公司 The method of Remote configuration infusion pump, storage medium, electronic equipment, infusion pump
AU2018354120A1 (en) 2017-10-24 2020-04-23 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
SG11202111673SA (en) 2019-05-20 2021-11-29 Unomedical As Rotatable infusion device and methods thereof
CN114887151A (en) * 2022-04-29 2022-08-12 深圳影迈科技有限公司 Infusion pump

Citations (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2605765A (en) 1947-06-05 1952-08-05 Kollsman Paul Automatic syringe
GB747701A (en) 1953-12-16 1956-04-11 Lines Bros Ltd Improvements in apparatus for controlling movements of model ships or other toys
US3886938A (en) 1973-10-23 1975-06-03 Scala Anthony Power operated fluid infusion device
US4077405A (en) 1975-03-26 1978-03-07 Siemens Aktiengesellschaft Apparatus for infusing liquids into human or animal bodies
US4231368A (en) 1978-03-23 1980-11-04 Michael Becker Device for intramuscular injections, especially of insulin
US4265241A (en) 1979-02-28 1981-05-05 Andros Incorporated Implantable infusion device
US4300554A (en) 1979-02-22 1981-11-17 Intermedicat Gmbh Portable infusion apparatus
US4313439A (en) 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
US4398908A (en) 1980-11-28 1983-08-16 Siposs George G Insulin delivery system
US4435173A (en) 1982-03-05 1984-03-06 Delta Medical Industries Variable rate syringe pump for insulin delivery
US4443218A (en) 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4493704A (en) 1982-11-29 1985-01-15 Oximetrix, Inc. Portable fluid infusion apparatus
US4529401A (en) 1982-01-11 1985-07-16 Cardiac Pacemakers, Inc. Ambulatory infusion pump having programmable parameters
US4850817A (en) 1987-12-01 1989-07-25 Pacesetter Infusion, Ltd. Mechanical drive system for a medication infusion system
GB2218831A (en) 1988-05-17 1989-11-22 Mark John Newland Personal medical apparatus
FR2585252B1 (en) 1985-07-26 1990-06-15 Gazuit Ste Nle Electronique SYRINGE DRIVER
US5045064A (en) 1990-06-01 1991-09-03 Infusaid, Inc. Constant pressure implantable pump reservoir
US5088981A (en) 1985-01-18 1992-02-18 Howson David C Safety enhanced device and method for effecting application of a therapeutic agent
US5190522A (en) 1989-01-20 1993-03-02 Institute Of Biocybernetics And Biomedical Engineering P.A.S. Device for monitoring the operation of a delivery system and the method of use thereof
US5250027A (en) 1991-10-08 1993-10-05 Sherwood Medical Company Peristaltic infusion device with backpack sensor
US5261882A (en) 1993-04-26 1993-11-16 Sealfon Andrew I Negator spring-powered syringe
US5314412A (en) 1991-04-17 1994-05-24 Novo Nordisk A S Manifold for a two barrel syringe
US5335994A (en) 1988-10-04 1994-08-09 G.I.R. Temperature monitoring device containing at least one element of an alloy which memorizes its shape
US5338157A (en) 1992-09-09 1994-08-16 Pharmacia Deltec, Inc. Systems and methods for communicating with ambulatory medical devices such as drug delivery devices
US5342180A (en) 1992-11-17 1994-08-30 Ivac Corporation Pump mechanism having a drive motor with an external rotor
US5395340A (en) 1993-03-15 1995-03-07 Lee; Tzium-Shou Infusion pump and a method for infusing patients using same
US5411487A (en) 1992-12-07 1995-05-02 Castagna; John F. Hypodermic syringe with automatic needle cover
EP0580723B1 (en) 1991-04-18 1995-10-25 Novo Nordisk A/S Infuser
US5545143A (en) 1993-01-21 1996-08-13 T. S. I. Medical Device for subcutaneous medication delivery
US5551850A (en) 1994-03-09 1996-09-03 Baxter International Inc. Pump chamber and valve assembly
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
EP0496141B1 (en) 1991-01-22 1997-04-02 Eli Lilly And Company Multiple dose injection pen
US5626566A (en) 1991-10-18 1997-05-06 Novo Nordisk A/S Large dose pen
US5637095A (en) 1995-01-13 1997-06-10 Minimed Inc. Medication infusion pump with flexible drive plunger
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
DE19627619A1 (en) 1996-07-09 1998-01-15 Orlita Prozesstechnik Orlita G Drive for diaphragm or piston pump for dosing of media, e.g. medicine into body
US5741216A (en) 1992-04-10 1998-04-21 Novo Nordisk A/S Pressure monitor
US5772635A (en) 1995-05-15 1998-06-30 Alaris Medical Systems, Inc. Automated infusion system with dose rate calculator
US5816306A (en) 1993-11-22 1998-10-06 Giacomel; Jeffrey A. Shape memory alloy actuator
US5852803A (en) 1992-03-20 1998-12-22 Chips International, Inc. Apparatus, system and method for recording and/or retrieving audio information
US5919167A (en) 1998-04-08 1999-07-06 Ferring Pharmaceuticals Disposable micropump
US5925018A (en) 1994-11-14 1999-07-20 Cma/Microdialysis Ab Infusion and microdialysis pump
US5928201A (en) 1996-07-05 1999-07-27 Novo Nordisk A/S Dose setting device
US5947934A (en) 1996-09-13 1999-09-07 Novo Nordisk A/S Dose display for an injection syringe
US5951530A (en) 1996-04-24 1999-09-14 Novo Nordisk A/S Injection needle
US5957889A (en) 1993-09-27 1999-09-28 Novo Nordisk A/S Displacement system for controlled infusion of a liquid
US5984894A (en) 1991-04-18 1999-11-16 Novo Nordisk A/S Infuser
US5984897A (en) 1993-04-01 1999-11-16 Novo Nordisk A/S Dispenser secured against reuse
US5997475A (en) 1997-08-18 1999-12-07 Solefound, Inc. Device for diabetes management
US6003736A (en) 1997-06-09 1999-12-21 Novo Nordisk A/S Device for controlled dispensing of a dose of a liquid contained in a cartridge
US6010485A (en) 1996-09-20 2000-01-04 Novo Nordisk A/S Working cylinder
US6033377A (en) 1997-02-04 2000-03-07 Novo Nordisk A/S Device for the administration of a liquid medicament suspension
US6045537A (en) 1995-06-02 2000-04-04 Novo Nordisk A/C Syringe with automatically withdrawable of piston rod
US6074372A (en) 1997-06-09 2000-06-13 Novo Nordisk A/S Dose setting mechanism and an injection syringe having such a dose setting mechanism
US6110149A (en) 1996-09-13 2000-08-29 Novo Nordisk A/S Syringe
EP0612004B2 (en) 1993-01-15 2000-10-04 Alaris Medical Systems, Inc. Configuration control system for configuring multiple biomedical devices
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
EP1045146A3 (en) 1999-04-14 2001-03-21 Clemens Micheler Medical dosing pump
US6231540B1 (en) 1997-07-14 2001-05-15 Novo Nordisk A/S Injection member
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6248093B1 (en) 1998-10-29 2001-06-19 Minimed Inc. Compact pump drive system
US6248090B1 (en) 1996-02-23 2001-06-19 Novo Nordisk A/S Syringe with electronic representation of parameters
US6277098B1 (en) 1996-03-12 2001-08-21 Novo Nordisk A/S Injection device with electronic presentation of set doses
EP1136698A1 (en) 2000-03-17 2001-09-26 Seiko Epson Corporation Temperature difference drive unit, and electric device, timepiece and light electrical appliance having the same
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
US6302869B1 (en) 1996-07-05 2001-10-16 Novo Nordisk A/S Syringe having a flexible piston rod
US20010056262A1 (en) 1998-05-21 2001-12-27 Oz Cabiri Adhesive system for medical devices
US20020004651A1 (en) 2000-04-13 2002-01-10 Henrik Ljunggreen Drug delivery device provided with a one-way mechanism
US20020007154A1 (en) 2000-05-04 2002-01-17 Steffen Hansen Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
US20020040208A1 (en) 2000-10-04 2002-04-04 Flaherty J. Christopher Data collection assembly for patient infusion system
US6375638B2 (en) 1999-02-12 2002-04-23 Medtronic Minimed, Inc. Incremental motion pump mechanisms powered by shape memory alloy wire or the like
US6379339B1 (en) 1996-09-13 2002-04-30 Nova Nordisk A/S Syringe
US6381496B1 (en) 1999-10-01 2002-04-30 Advanced Bionics Corporation Parameter context switching for an implanted device
EP0721358B1 (en) 1993-09-27 2002-05-08 Novo Nordisk A/S Displacement system for controlled infusion of a liquid
US6404098B1 (en) 1999-04-15 2002-06-11 Sony Corporation Drive unit using shape memory alloy
US20020091358A1 (en) 2000-10-05 2002-07-11 Klitmose Lars Peter Medication delivery device with bended piston rod
US6427088B1 (en) 2000-01-21 2002-07-30 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
US20020126036A1 (en) 2000-12-21 2002-09-12 Flaherty J. Christopher Medical apparatus remote control and method
US6461331B1 (en) 1999-05-21 2002-10-08 Minimed Inc. Device and method for infusion of small molecule insulin mimetic materials
US6474219B2 (en) 2000-03-24 2002-11-05 Novo Nordisk A/S Flexible piston rod
US6485461B1 (en) 2000-04-04 2002-11-26 Insulet, Inc. Disposable infusion device
US6508788B2 (en) 2000-10-27 2003-01-21 Novo Nordisk A/S Medication delivery device with telescopic piston rod
US6524280B2 (en) 2000-01-28 2003-02-25 Noro Nordisk A/S Dose setting limiter
US6533183B2 (en) 2000-05-03 2003-03-18 Novo Nordisk A/S Coding of cartridges for an injection device
US20030055380A1 (en) 2001-09-19 2003-03-20 Flaherty J. Christopher Plunger for patient infusion device
US6540672B1 (en) 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
US6544229B1 (en) 2000-05-01 2003-04-08 Baxter International Inc Linearly motile infusion pump
US6547764B2 (en) 2000-05-31 2003-04-15 Novo Nordisk A/S Double pointed injection needle
US6551276B1 (en) 1998-08-18 2003-04-22 Medtronic Minimed, Inc. External infusion device with remote programming bolus estimator and/or vibration alarm capabilities
US6554800B1 (en) 2000-08-09 2003-04-29 Medtronic Minimed, Inc. Compact pump motor system and dispensing process
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US20030088238A1 (en) 2001-09-26 2003-05-08 Poulsen Jens Ulrik Modular drug delivery system
US6562011B1 (en) 1998-07-08 2003-05-13 Novo Nordisk A/S Medication delivery device
US6569126B1 (en) 1997-07-14 2003-05-27 Novo Nordisk A/S Cylinder ampoule
US6582404B1 (en) 1999-09-16 2003-06-24 Nna/S Dose setting limiter
US6605067B1 (en) 1998-11-20 2003-08-12 Novo Nordisk A/S Injection needle
US6613019B2 (en) 2000-07-14 2003-09-02 Novo Nordisk A/S Liquid medication delivery device and a method of delivering an intended dose
US20030199825A1 (en) 2002-04-23 2003-10-23 Flaherty J. Christopher Dispenser for patient infusion device
US6650951B1 (en) 2000-06-19 2003-11-18 International Business Machines Corporation Method and insulin pump for providing a forgotten bolus warning
US20030216683A1 (en) 2001-11-26 2003-11-20 Nili-Med Ltd. Drug delivery device and method
US6656158B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US6659980B2 (en) 2000-03-29 2003-12-09 Medtronic Minimed Inc Methods, apparatuses, and uses for infusion pump fluid pressure and force detection
US6659978B1 (en) 1999-10-04 2003-12-09 Seiko Instruments Inc. Portable dosing apparatus
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
US6669669B2 (en) 2001-10-12 2003-12-30 Insulet Corporation Laminated patient infusion device
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US20040019325A1 (en) 2002-07-29 2004-01-29 Medrip Ltd. Syringe Pump
US6691043B2 (en) 2001-08-28 2004-02-10 Maxi-Med, Llc Bolus calculator
US6690192B1 (en) 2002-10-16 2004-02-10 Pericom Semiconductor Corp. Current-compensated CMOS output buffer adjusting edge rate for process, temperature, and Vcc variations
US6692457B2 (en) 2002-03-01 2004-02-17 Insulet Corporation Flow condition sensor assembly for patient infusion device
DE10236669A1 (en) 2002-08-09 2004-02-19 Korszak, Dieter Pen for administration of insulin injections, comprising LED to display amount to be injected, acoustic repeat and timer to give visual and acoustic indications of dosages and timings
US6699218B2 (en) 2000-11-09 2004-03-02 Insulet Corporation Transcutaneous delivery means
US6702779B2 (en) 2000-08-18 2004-03-09 Becton, Dickinson And Company Constant rate fluid delivery device with selectable flow rate and titratable bolus button
US20040064096A1 (en) 2002-09-30 2004-04-01 Flaherty J. Christopher Components and methods for patient infusion device
US20040064088A1 (en) 2002-09-30 2004-04-01 William Gorman Dispenser components and methods for patient infusion device
US6715516B2 (en) 2001-12-19 2004-04-06 Novo Nordisk A/S Method and apparatus for filling cartridges with a liquid
US6716198B2 (en) 2000-05-18 2004-04-06 Novo Nordisk A/S Injection device
US6723072B2 (en) 2002-06-06 2004-04-20 Insulet Corporation Plunger assembly for patient infusion device
US20040078028A1 (en) 2001-11-09 2004-04-22 Flaherty J. Christopher Plunger assembly for patient infusion device
US20040087894A1 (en) 2000-09-08 2004-05-06 Flaherty J. Christopher Devices, systems and methods for patient infusion
US6736796B2 (en) 2001-11-26 2004-05-18 Nili-Med Ltd. Fluid drug delivery device
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US6744350B2 (en) 2002-02-28 2004-06-01 Smiths Medical Md, Inc. Insulin pump having missed meal bolus alarm
US6749587B2 (en) 2001-02-22 2004-06-15 Insulet Corporation Modular infusion device and method
US20040116866A1 (en) 2002-12-17 2004-06-17 William Gorman Skin attachment apparatus and method for patient infusion device
US6752787B1 (en) 1999-06-08 2004-06-22 Medtronic Minimed, Inc., Cost-sensitive application infusion device
US20040153032A1 (en) 2002-04-23 2004-08-05 Garribotto John T. Dispenser for patient infusion device
US6780156B2 (en) 1998-09-08 2004-08-24 Disetronic Licensing Ag Module for a computer interface
US20040171983A1 (en) 2003-02-24 2004-09-02 Integrated Sensing Systems, Inc. Fluid delivery system and sensing unit therefor
US6786890B2 (en) 2002-01-25 2004-09-07 Novo Nordisk A/S Linear actuator and a medical delivery device comprising such linear actuator
US6799149B2 (en) 2000-12-29 2004-09-28 Medtronic, Inc. Therapy management techniques for an implantable medical device
US6796970B1 (en) 1997-06-17 2004-09-28 Novo Nordisk A/S Dose setting device
EP1177802B1 (en) 2000-07-31 2004-09-29 Becton Dickinson and Company Wearable, self-contained drug infusion device
US6809653B1 (en) 1998-10-08 2004-10-26 Medtronic Minimed, Inc. Telemetered characteristic monitor system and method of using the same
US20040220551A1 (en) 2003-04-30 2004-11-04 Flaherty J. Christopher Low profile components for patient infusion device
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US6830558B2 (en) 2002-03-01 2004-12-14 Insulet Corporation Flow condition sensor assembly for patient infusion device
US20040260233A1 (en) 2000-09-08 2004-12-23 Garibotto John T. Data collection assembly for patient infusion system
EP1495775A1 (en) 2003-07-08 2005-01-12 Novo Nordisk A/S Portable drug delivery device having an encapsulated needle
US20050022274A1 (en) 2003-04-18 2005-01-27 Robert Campbell User interface for infusion pump remote controller and method of using the same
US6852104B2 (en) 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
US6854620B2 (en) 2001-04-13 2005-02-15 Nipro Diabetes, Systems, Inc. Drive system for an infusion pump
US6854653B2 (en) 2000-08-10 2005-02-15 Novo Nordisk A/S Electronic marking of a medication cartridge
US6855129B2 (en) 2001-11-30 2005-02-15 Novo Nordisk A/S Safety needle assembly
US20050038332A1 (en) * 2001-12-27 2005-02-17 Frank Saidara System for monitoring physiological characteristics
US20050065760A1 (en) 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
US6878132B2 (en) 1999-10-05 2005-04-12 Disetronic Licensing Ag Device for administering an injectable product in doses
US20050090808A1 (en) 2003-04-30 2005-04-28 Luis Malave Multi-processor medical device
EP1527792A1 (en) 2003-10-27 2005-05-04 Novo Nordisk A/S Medical injection device mountable to the skin
US20050095063A1 (en) 2003-10-30 2005-05-05 Fathallah Marwan A. Medical device system
CA2543545A1 (en) 2003-10-21 2005-05-06 Ole Christian Nielsen Medical injection device mountable to the skin
US6893415B2 (en) 2000-09-22 2005-05-17 Novo Nordisk A/S Medication delivery device
US6899695B2 (en) 2003-08-08 2005-05-31 Hector J. Herrera Medication security apparatus and method
US6899699B2 (en) 2001-01-05 2005-05-31 Novo Nordisk A/S Automatic injection device with reset feature
US6922590B1 (en) 2000-11-21 2005-07-26 Advanced Bionics Corporation Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US20050160858A1 (en) 2002-07-24 2005-07-28 M 2 Medical A/S Shape memory alloy actuator
US20050182366A1 (en) 2003-04-18 2005-08-18 Insulet Corporation Method For Visual Output Verification
US6936006B2 (en) 2002-03-22 2005-08-30 Novo Nordisk, A/S Atraumatic insertion of a subcutaneous device
US20050192561A1 (en) 2002-07-24 2005-09-01 M 2 Medical A/S Infusion pump system, an infusion pump unit and an infusion pump
US20050203461A1 (en) 2002-04-23 2005-09-15 Insulet Corporation Transcutaneous fluid delivery system
US6945961B2 (en) 2002-07-10 2005-09-20 Novo Nordisk A/S Injection device
US6948918B2 (en) 2002-09-27 2005-09-27 Novo Nordisk A/S Membrane pump with stretchable pump membrane
US20050238507A1 (en) 2002-04-23 2005-10-27 Insulet Corporation Fluid delivery device
US20050245878A1 (en) 2002-11-05 2005-11-03 M 2 Medical A/S Disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US20050251097A1 (en) 2002-12-23 2005-11-10 M 2 Medical A/S Flexible piston rod
US20050267402A1 (en) 2004-05-27 2005-12-01 Janice Stewart Multi-state alarm system for a medical pump
US20050273059A1 (en) 2002-12-23 2005-12-08 M 2 Medical A/S Disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US6997911B2 (en) 2000-05-30 2006-02-14 Novo Nordisk A/S Medication delivery device with replaceable cooperating modules and a method of making same
US20060041229A1 (en) 2002-07-16 2006-02-23 Insulet Corporation Flow restriction system and method for patient infusion device
US7005078B2 (en) 2000-05-25 2006-02-28 Debiotech Sa Micromachined fluidic device and method for making same
US7008399B2 (en) 2001-02-14 2006-03-07 Novo Nordisk A/S Electronically controlled device
US7014625B2 (en) 2002-10-07 2006-03-21 Novo Nordick A/S Needle insertion device
US20060069382A1 (en) 2003-04-11 2006-03-30 Novo Nordisk A/S Delivery device
US20060095014A1 (en) 2003-05-08 2006-05-04 Novo Nordisk A/S External inserter for transcutaneous device
US7054836B2 (en) 2000-11-30 2006-05-30 Novo Nordisk A/S Method for assisting a customer in building a build-to-order medical device
US20060135913A1 (en) 2003-05-08 2006-06-22 Novo Nordisk A/S Pivotable needle unit
US20060142698A1 (en) 2003-05-08 2006-06-29 Novo Nordisk A/S Internal needle inserter
US20060178633A1 (en) 2005-02-03 2006-08-10 Insulet Corporation Chassis for fluid delivery device
US20060184119A1 (en) 2003-06-17 2006-08-17 Axel Remde Modular infusion pump
US20060200073A1 (en) 2003-07-08 2006-09-07 Novo Nordisk A/S Portable drug delivery device having an encapsulated needle
US7104972B2 (en) 2002-07-10 2006-09-12 Novo Nordisk A/S Injection device with a dose setting limiter
US20060206054A1 (en) 2001-11-26 2006-09-14 Nilimedix Ltd. Drug delivery device and method
US20060247581A1 (en) 2003-09-08 2006-11-02 Novo Nordisk A/S Threaded rod and nut assembly
US7133329B2 (en) 2002-07-23 2006-11-07 Novo Nordisk A/S Device with time indicating means
EP1754498A1 (en) 2005-08-19 2007-02-21 Roche Diagnostics GmbH Driving device for an injection or infusion device
US20070073236A1 (en) 2005-09-26 2007-03-29 Morten Mernoe Dispensing fluid from an infusion pump system
US20070073228A1 (en) 2005-09-26 2007-03-29 Morten Mernoe Dispensing fluid from an infusion pump system
US20070124002A1 (en) 2005-11-08 2007-05-31 M2 Medical A/S Method and System for Manual and Autonomous Control of an Infusion Pump
US20070156092A1 (en) 2005-09-26 2007-07-05 M2 Medical A/S Operating an Infusion Pump System
US20070167912A1 (en) 2005-09-26 2007-07-19 M2 Medical A/S Operating an Infusion Pump System
US20080208627A1 (en) 2005-03-17 2008-08-28 Ole Skyggebjerg Securing Pairing of Electronic Devices

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005A (en) * 1841-03-16 Improvement in the manner of constructing molds for casting butt-hinges
US5669877A (en) * 1994-03-07 1997-09-23 Sims Deltec, Inc. Systems and methods for automated testing of medical equipment
US4731051A (en) 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
AU5933490A (en) 1989-06-21 1991-01-08 Johnson Service Company A shape memory actuator
US5858001A (en) 1995-12-11 1999-01-12 Elan Medical Technologies Limited Cartridge-based drug delivery device
GB2342188B (en) * 1996-04-10 2000-07-12 Baxter Int Infusion pump
WO1998011927A1 (en) 1996-09-20 1998-03-26 Disetronic Licensing Ag Expulsion member for advancing the stopper of a syringe ampoule and a corresponding stopper
CA2294612A1 (en) 1997-06-16 1998-12-23 Elan Corporation Plc Pre-filled drug-delivery device and method of manufacture and assembly of same
ATE293465T1 (en) 1997-10-23 2005-05-15 Morten Mernoe INFUSION PUMP SYSTEM AND UNIT
WO1999039118A1 (en) 1998-02-03 1999-08-05 The Board Of Trustees Operating Michigan State University Et Al. Thin film fluid control systems and method of fabricating the same
DE69913111T2 (en) 1998-03-23 2004-06-03 Elan Corp. Plc DEVICE FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
JP4703083B2 (en) 2000-01-21 2011-06-15 メドトロニック ミニメド インコーポレイテッド Medical system
WO2001072208A2 (en) * 2000-03-29 2001-10-04 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
KR20030005135A (en) 2000-05-30 2003-01-15 노보 노르디스크 에이/에스 A medication delivery device with replaceable cooperating modules and a method of making same
AU2001263946A1 (en) 2000-05-31 2001-12-11 Mnemoscience Gmbh Shape memory thermoplastics and polymer networks for tissue engineering
US6735479B2 (en) 2000-06-14 2004-05-11 Medtronic, Inc. Lifestyle management system
EP1296744A2 (en) 2000-06-23 2003-04-02 Medtronic, Inc. Network compatible rf wireless link for medical device data management
US20020027164A1 (en) * 2000-09-07 2002-03-07 Mault James R. Portable computing apparatus particularly useful in a weight management program
EP1364125A1 (en) 2001-01-17 2003-11-26 M 2 Medical A/S Shape memory alloy actuator
AU2002345757A1 (en) 2001-06-11 2002-12-23 Glaxo Group Limited Medicament dispenser for containers of varying sizes
US7179226B2 (en) * 2001-06-21 2007-02-20 Animas Corporation System and method for managing diabetes
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
WO2003009208A1 (en) 2001-07-20 2003-01-30 Medical Research Group Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
FI20021031A (en) * 2001-12-28 2003-06-29 Pertti Laehteenmaeki Nutritional Machine
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
US8250483B2 (en) * 2002-02-28 2012-08-21 Smiths Medical Asd, Inc. Programmable medical infusion pump displaying a banner
US20080132842A1 (en) 2002-06-06 2008-06-05 Flaherty J Christopher Plunger assembly for patient infusion device
US7018361B2 (en) 2002-06-14 2006-03-28 Baxter International Inc. Infusion pump
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US7617132B2 (en) * 2002-11-21 2009-11-10 Kimberly-Clark Worldwide, Inc. RFID system and method for ensuring food safety
US7835927B2 (en) 2002-12-27 2010-11-16 Carefusion 303, Inc. Medication management system
DE10330094B4 (en) 2003-07-03 2008-04-17 Disetronic Licensing Ag Device for administering a liquid product
US8065161B2 (en) 2003-11-13 2011-11-22 Hospira, Inc. System for maintaining drug information and communicating with medication delivery devices
US20050096637A1 (en) 2003-10-31 2005-05-05 Medtronic, Inc. Sensing food intake
WO2005072795A2 (en) 2004-01-29 2005-08-11 M 2 Medical A/S Disposable medicine dispensing device
US7753879B2 (en) 2004-01-29 2010-07-13 M2 Group Holdings, Inc. Disposable medicine dispensing device
US20060036395A1 (en) 2004-07-30 2006-02-16 Shaya Steven A Method and apparatus for measuring and controlling food intake of an individual
WO2006105793A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S Method and device for dispensing liquid medicine by means of a twistable element
US20070060869A1 (en) 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump
WO2008089184A2 (en) 2007-01-15 2008-07-24 Deka Products Limited Partnership Device and method for food management

Patent Citations (246)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2605765A (en) 1947-06-05 1952-08-05 Kollsman Paul Automatic syringe
GB747701A (en) 1953-12-16 1956-04-11 Lines Bros Ltd Improvements in apparatus for controlling movements of model ships or other toys
US3886938A (en) 1973-10-23 1975-06-03 Scala Anthony Power operated fluid infusion device
US4077405A (en) 1975-03-26 1978-03-07 Siemens Aktiengesellschaft Apparatus for infusing liquids into human or animal bodies
US4231368A (en) 1978-03-23 1980-11-04 Michael Becker Device for intramuscular injections, especially of insulin
US4300554A (en) 1979-02-22 1981-11-17 Intermedicat Gmbh Portable infusion apparatus
US4265241A (en) 1979-02-28 1981-05-05 Andros Incorporated Implantable infusion device
US4313439A (en) 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
US4398908A (en) 1980-11-28 1983-08-16 Siposs George G Insulin delivery system
US4529401A (en) 1982-01-11 1985-07-16 Cardiac Pacemakers, Inc. Ambulatory infusion pump having programmable parameters
US4435173A (en) 1982-03-05 1984-03-06 Delta Medical Industries Variable rate syringe pump for insulin delivery
US4443218A (en) 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4493704A (en) 1982-11-29 1985-01-15 Oximetrix, Inc. Portable fluid infusion apparatus
US5088981A (en) 1985-01-18 1992-02-18 Howson David C Safety enhanced device and method for effecting application of a therapeutic agent
FR2585252B1 (en) 1985-07-26 1990-06-15 Gazuit Ste Nle Electronique SYRINGE DRIVER
US4850817A (en) 1987-12-01 1989-07-25 Pacesetter Infusion, Ltd. Mechanical drive system for a medication infusion system
GB2218831A (en) 1988-05-17 1989-11-22 Mark John Newland Personal medical apparatus
US5335994A (en) 1988-10-04 1994-08-09 G.I.R. Temperature monitoring device containing at least one element of an alloy which memorizes its shape
US5190522A (en) 1989-01-20 1993-03-02 Institute Of Biocybernetics And Biomedical Engineering P.A.S. Device for monitoring the operation of a delivery system and the method of use thereof
US5045064A (en) 1990-06-01 1991-09-03 Infusaid, Inc. Constant pressure implantable pump reservoir
EP0496141B1 (en) 1991-01-22 1997-04-02 Eli Lilly And Company Multiple dose injection pen
US5314412A (en) 1991-04-17 1994-05-24 Novo Nordisk A S Manifold for a two barrel syringe
EP0580723B1 (en) 1991-04-18 1995-10-25 Novo Nordisk A/S Infuser
US5984894A (en) 1991-04-18 1999-11-16 Novo Nordisk A/S Infuser
US5250027A (en) 1991-10-08 1993-10-05 Sherwood Medical Company Peristaltic infusion device with backpack sensor
US5626566A (en) 1991-10-18 1997-05-06 Novo Nordisk A/S Large dose pen
US5852803A (en) 1992-03-20 1998-12-22 Chips International, Inc. Apparatus, system and method for recording and/or retrieving audio information
US5741216A (en) 1992-04-10 1998-04-21 Novo Nordisk A/S Pressure monitor
US5338157A (en) 1992-09-09 1994-08-16 Pharmacia Deltec, Inc. Systems and methods for communicating with ambulatory medical devices such as drug delivery devices
US5338157B1 (en) 1992-09-09 1999-11-02 Sims Deltec Inc Systems and methods for communicating with ambulat
US5342180A (en) 1992-11-17 1994-08-30 Ivac Corporation Pump mechanism having a drive motor with an external rotor
US5411487A (en) 1992-12-07 1995-05-02 Castagna; John F. Hypodermic syringe with automatic needle cover
EP0612004B2 (en) 1993-01-15 2000-10-04 Alaris Medical Systems, Inc. Configuration control system for configuring multiple biomedical devices
US5545143A (en) 1993-01-21 1996-08-13 T. S. I. Medical Device for subcutaneous medication delivery
US5395340A (en) 1993-03-15 1995-03-07 Lee; Tzium-Shou Infusion pump and a method for infusing patients using same
US5984897A (en) 1993-04-01 1999-11-16 Novo Nordisk A/S Dispenser secured against reuse
US6156014A (en) 1993-04-01 2000-12-05 Novo Nordisk A/S Dispenser secured against reuse
US5261882A (en) 1993-04-26 1993-11-16 Sealfon Andrew I Negator spring-powered syringe
US5957889A (en) 1993-09-27 1999-09-28 Novo Nordisk A/S Displacement system for controlled infusion of a liquid
EP0721358B1 (en) 1993-09-27 2002-05-08 Novo Nordisk A/S Displacement system for controlled infusion of a liquid
US5816306A (en) 1993-11-22 1998-10-06 Giacomel; Jeffrey A. Shape memory alloy actuator
US5551850A (en) 1994-03-09 1996-09-03 Baxter International Inc. Pump chamber and valve assembly
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5925018A (en) 1994-11-14 1999-07-20 Cma/Microdialysis Ab Infusion and microdialysis pump
US5637095A (en) 1995-01-13 1997-06-10 Minimed Inc. Medication infusion pump with flexible drive plunger
US5772635A (en) 1995-05-15 1998-06-30 Alaris Medical Systems, Inc. Automated infusion system with dose rate calculator
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6045537A (en) 1995-06-02 2000-04-04 Novo Nordisk A/C Syringe with automatically withdrawable of piston rod
US6248090B1 (en) 1996-02-23 2001-06-19 Novo Nordisk A/S Syringe with electronic representation of parameters
US6277098B1 (en) 1996-03-12 2001-08-21 Novo Nordisk A/S Injection device with electronic presentation of set doses
US5951530A (en) 1996-04-24 1999-09-14 Novo Nordisk A/S Injection needle
US6302869B1 (en) 1996-07-05 2001-10-16 Novo Nordisk A/S Syringe having a flexible piston rod
US5928201A (en) 1996-07-05 1999-07-27 Novo Nordisk A/S Dose setting device
DE19627619A1 (en) 1996-07-09 1998-01-15 Orlita Prozesstechnik Orlita G Drive for diaphragm or piston pump for dosing of media, e.g. medicine into body
US5947934A (en) 1996-09-13 1999-09-07 Novo Nordisk A/S Dose display for an injection syringe
US6110149A (en) 1996-09-13 2000-08-29 Novo Nordisk A/S Syringe
US6379339B1 (en) 1996-09-13 2002-04-30 Nova Nordisk A/S Syringe
US6010485A (en) 1996-09-20 2000-01-04 Novo Nordisk A/S Working cylinder
US6033377A (en) 1997-02-04 2000-03-07 Novo Nordisk A/S Device for the administration of a liquid medicament suspension
US6074372A (en) 1997-06-09 2000-06-13 Novo Nordisk A/S Dose setting mechanism and an injection syringe having such a dose setting mechanism
US6003736A (en) 1997-06-09 1999-12-21 Novo Nordisk A/S Device for controlled dispensing of a dose of a liquid contained in a cartridge
US6796970B1 (en) 1997-06-17 2004-09-28 Novo Nordisk A/S Dose setting device
US6231540B1 (en) 1997-07-14 2001-05-15 Novo Nordisk A/S Injection member
US6569126B1 (en) 1997-07-14 2003-05-27 Novo Nordisk A/S Cylinder ampoule
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US5997475A (en) 1997-08-18 1999-12-07 Solefound, Inc. Device for diabetes management
US5919167A (en) 1998-04-08 1999-07-06 Ferring Pharmaceuticals Disposable micropump
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
US20010056262A1 (en) 1998-05-21 2001-12-27 Oz Cabiri Adhesive system for medical devices
US6562011B1 (en) 1998-07-08 2003-05-13 Novo Nordisk A/S Medication delivery device
US6979326B2 (en) 1998-08-18 2005-12-27 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6872200B2 (en) 1998-08-18 2005-03-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US20080147050A1 (en) * 1998-08-18 2008-06-19 Medtronic Minimed Inc. External Infusion Device With Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities
US6997920B2 (en) 1998-08-18 2006-02-14 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US7025743B2 (en) 1998-08-18 2006-04-11 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6551276B1 (en) 1998-08-18 2003-04-22 Medtronic Minimed, Inc. External infusion device with remote programming bolus estimator and/or vibration alarm capabilities
US6936029B2 (en) 1998-08-18 2005-08-30 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6641533B2 (en) 1998-08-18 2003-11-04 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6780156B2 (en) 1998-09-08 2004-08-24 Disetronic Licensing Ag Module for a computer interface
US6809653B1 (en) 1998-10-08 2004-10-26 Medtronic Minimed, Inc. Telemetered characteristic monitor system and method of using the same
US6248093B1 (en) 1998-10-29 2001-06-19 Minimed Inc. Compact pump drive system
US6605067B1 (en) 1998-11-20 2003-08-12 Novo Nordisk A/S Injection needle
US6540672B1 (en) 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6375638B2 (en) 1999-02-12 2002-04-23 Medtronic Minimed, Inc. Incremental motion pump mechanisms powered by shape memory alloy wire or the like
EP1045146A3 (en) 1999-04-14 2001-03-21 Clemens Micheler Medical dosing pump
US6404098B1 (en) 1999-04-15 2002-06-11 Sony Corporation Drive unit using shape memory alloy
US6461331B1 (en) 1999-05-21 2002-10-08 Minimed Inc. Device and method for infusion of small molecule insulin mimetic materials
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6752787B1 (en) 1999-06-08 2004-06-22 Medtronic Minimed, Inc., Cost-sensitive application infusion device
US6582404B1 (en) 1999-09-16 2003-06-24 Nna/S Dose setting limiter
US6381496B1 (en) 1999-10-01 2002-04-30 Advanced Bionics Corporation Parameter context switching for an implanted device
US6659978B1 (en) 1999-10-04 2003-12-09 Seiko Instruments Inc. Portable dosing apparatus
US6878132B2 (en) 1999-10-05 2005-04-12 Disetronic Licensing Ag Device for administering an injectable product in doses
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6873268B2 (en) 2000-01-21 2005-03-29 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US20030065308A1 (en) 2000-01-21 2003-04-03 Lebel Ronald J. Ambulatory medical apparatus with hand held communication device
US6564105B2 (en) 2000-01-21 2003-05-13 Medtronic Minimed, Inc. Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US6562001B2 (en) 2000-01-21 2003-05-13 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6810290B2 (en) 2000-01-21 2004-10-26 Medtronic Minimed, Inc. Ambulatory medical apparatus with hand held communication device
US6668196B1 (en) 2000-01-21 2003-12-23 Medical Research Group, Inc. Ambulatory medical apparatus with hand held communication device
US6571128B2 (en) 2000-01-21 2003-05-27 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6577899B2 (en) 2000-01-21 2003-06-10 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6758810B2 (en) 2000-01-21 2004-07-06 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6813519B2 (en) 2000-01-21 2004-11-02 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6585644B2 (en) 2000-01-21 2003-07-01 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US6659948B2 (en) 2000-01-21 2003-12-09 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US6811533B2 (en) 2000-01-21 2004-11-02 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6811534B2 (en) 2000-01-21 2004-11-02 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US6740075B2 (en) 2000-01-21 2004-05-25 Medtronic Minimed, Inc. Ambulatory medical apparatus with hand held communication device
US6733446B2 (en) 2000-01-21 2004-05-11 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US6648821B2 (en) 2000-01-21 2003-11-18 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6950708B2 (en) 2000-01-21 2005-09-27 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening
US6427088B1 (en) 2000-01-21 2002-07-30 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
US6694191B2 (en) 2000-01-21 2004-02-17 Medtronic Minimed, Inc. Ambulatory medical apparatus and method having telemetry modifiable control software
US6687546B2 (en) 2000-01-21 2004-02-03 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6524280B2 (en) 2000-01-28 2003-02-25 Noro Nordisk A/S Dose setting limiter
EP1136698A1 (en) 2000-03-17 2001-09-26 Seiko Epson Corporation Temperature difference drive unit, and electric device, timepiece and light electrical appliance having the same
US6474219B2 (en) 2000-03-24 2002-11-05 Novo Nordisk A/S Flexible piston rod
US6659980B2 (en) 2000-03-29 2003-12-09 Medtronic Minimed Inc Methods, apparatuses, and uses for infusion pump fluid pressure and force detection
US6485461B1 (en) 2000-04-04 2002-11-26 Insulet, Inc. Disposable infusion device
US20020004651A1 (en) 2000-04-13 2002-01-10 Henrik Ljunggreen Drug delivery device provided with a one-way mechanism
US6585699B2 (en) 2000-04-13 2003-07-01 Nna/S Drug delivery device provided with a one-way mechanism
US6544229B1 (en) 2000-05-01 2003-04-08 Baxter International Inc Linearly motile infusion pump
US6533183B2 (en) 2000-05-03 2003-03-18 Novo Nordisk A/S Coding of cartridges for an injection device
US20020007154A1 (en) 2000-05-04 2002-01-17 Steffen Hansen Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
US6692472B2 (en) 2000-05-04 2004-02-17 Novo Nordisk A/S Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
US6716198B2 (en) 2000-05-18 2004-04-06 Novo Nordisk A/S Injection device
US7005078B2 (en) 2000-05-25 2006-02-28 Debiotech Sa Micromachined fluidic device and method for making same
US6997911B2 (en) 2000-05-30 2006-02-14 Novo Nordisk A/S Medication delivery device with replaceable cooperating modules and a method of making same
US6547764B2 (en) 2000-05-31 2003-04-15 Novo Nordisk A/S Double pointed injection needle
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
US6650951B1 (en) 2000-06-19 2003-11-18 International Business Machines Corporation Method and insulin pump for providing a forgotten bolus warning
US6613019B2 (en) 2000-07-14 2003-09-02 Novo Nordisk A/S Liquid medication delivery device and a method of delivering an intended dose
EP1177802B1 (en) 2000-07-31 2004-09-29 Becton Dickinson and Company Wearable, self-contained drug infusion device
US6554800B1 (en) 2000-08-09 2003-04-29 Medtronic Minimed, Inc. Compact pump motor system and dispensing process
US6854653B2 (en) 2000-08-10 2005-02-15 Novo Nordisk A/S Electronic marking of a medication cartridge
US6702779B2 (en) 2000-08-18 2004-03-09 Becton, Dickinson And Company Constant rate fluid delivery device with selectable flow rate and titratable bolus button
US20040087894A1 (en) 2000-09-08 2004-05-06 Flaherty J. Christopher Devices, systems and methods for patient infusion
US7029455B2 (en) 2000-09-08 2006-04-18 Insulet Corporation Devices, systems and methods for patient infusion
US20050171512A1 (en) * 2000-09-08 2005-08-04 Insulet Corporation Devices, systems and methods for patient infusion
US20040260233A1 (en) 2000-09-08 2004-12-23 Garibotto John T. Data collection assembly for patient infusion system
US6740059B2 (en) 2000-09-08 2004-05-25 Insulet Corporation Devices, systems and methods for patient infusion
US6893415B2 (en) 2000-09-22 2005-05-17 Novo Nordisk A/S Medication delivery device
US20020040208A1 (en) 2000-10-04 2002-04-04 Flaherty J. Christopher Data collection assembly for patient infusion system
US20020091358A1 (en) 2000-10-05 2002-07-11 Klitmose Lars Peter Medication delivery device with bended piston rod
US6537251B2 (en) 2000-10-05 2003-03-25 Novo Nordisk A/S Medication delivery device with bended piston rod
US6508788B2 (en) 2000-10-27 2003-01-21 Novo Nordisk A/S Medication delivery device with telescopic piston rod
US6699218B2 (en) 2000-11-09 2004-03-02 Insulet Corporation Transcutaneous delivery means
US6922590B1 (en) 2000-11-21 2005-07-26 Advanced Bionics Corporation Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US7054836B2 (en) 2000-11-30 2006-05-30 Novo Nordisk A/S Method for assisting a customer in building a build-to-order medical device
US20020126036A1 (en) 2000-12-21 2002-09-12 Flaherty J. Christopher Medical apparatus remote control and method
US20040235446A1 (en) 2000-12-21 2004-11-25 Flaherty J. Christopher Medical apparatus remote control and method
US6768425B2 (en) 2000-12-21 2004-07-27 Insulet Corporation Medical apparatus remote control and method
US6799149B2 (en) 2000-12-29 2004-09-28 Medtronic, Inc. Therapy management techniques for an implantable medical device
US6899699B2 (en) 2001-01-05 2005-05-31 Novo Nordisk A/S Automatic injection device with reset feature
US7008399B2 (en) 2001-02-14 2006-03-07 Novo Nordisk A/S Electronically controlled device
US20040204673A1 (en) 2001-02-22 2004-10-14 Flaherty J. Christopher Modular infusion device and method
US6749587B2 (en) 2001-02-22 2004-06-15 Insulet Corporation Modular infusion device and method
US6854620B2 (en) 2001-04-13 2005-02-15 Nipro Diabetes, Systems, Inc. Drive system for an infusion pump
US6691043B2 (en) 2001-08-28 2004-02-10 Maxi-Med, Llc Bolus calculator
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US20030055380A1 (en) 2001-09-19 2003-03-20 Flaherty J. Christopher Plunger for patient infusion device
US20040092878A1 (en) 2001-09-19 2004-05-13 Flaherty J. Christopher Plunger for patient infusion device
US20030088238A1 (en) 2001-09-26 2003-05-08 Poulsen Jens Ulrik Modular drug delivery system
US6669669B2 (en) 2001-10-12 2003-12-30 Insulet Corporation Laminated patient infusion device
US20050021005A1 (en) 2001-10-12 2005-01-27 Flaherty J. Christopher Laminated patient infusion device
US20040078028A1 (en) 2001-11-09 2004-04-22 Flaherty J. Christopher Plunger assembly for patient infusion device
US20040092865A1 (en) 2001-11-09 2004-05-13 J. Christopher Flaherty Transcutaneous delivery means
US6736796B2 (en) 2001-11-26 2004-05-18 Nili-Med Ltd. Fluid drug delivery device
US20040176727A1 (en) 2001-11-26 2004-09-09 Avraham Shekalim Insulin pump
US20030216683A1 (en) 2001-11-26 2003-11-20 Nili-Med Ltd. Drug delivery device and method
US20060206054A1 (en) 2001-11-26 2006-09-14 Nilimedix Ltd. Drug delivery device and method
US6855129B2 (en) 2001-11-30 2005-02-15 Novo Nordisk A/S Safety needle assembly
US6786246B2 (en) 2001-12-19 2004-09-07 Novo Nordisk A/S Method and apparatus for filling cartridges with a liquid
US6715516B2 (en) 2001-12-19 2004-04-06 Novo Nordisk A/S Method and apparatus for filling cartridges with a liquid
US20050038332A1 (en) * 2001-12-27 2005-02-17 Frank Saidara System for monitoring physiological characteristics
US6786890B2 (en) 2002-01-25 2004-09-07 Novo Nordisk A/S Linear actuator and a medical delivery device comprising such linear actuator
US6852104B2 (en) 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
US6744350B2 (en) 2002-02-28 2004-06-01 Smiths Medical Md, Inc. Insulin pump having missed meal bolus alarm
US6830558B2 (en) 2002-03-01 2004-12-14 Insulet Corporation Flow condition sensor assembly for patient infusion device
US6692457B2 (en) 2002-03-01 2004-02-17 Insulet Corporation Flow condition sensor assembly for patient infusion device
US20040127844A1 (en) 2002-03-01 2004-07-01 Flaherty J. Christopher Flow condition sensor assembly for patient infusion device
US6936006B2 (en) 2002-03-22 2005-08-30 Novo Nordisk, A/S Atraumatic insertion of a subcutaneous device
US6656158B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US20030199825A1 (en) 2002-04-23 2003-10-23 Flaherty J. Christopher Dispenser for patient infusion device
US20040153032A1 (en) 2002-04-23 2004-08-05 Garribotto John T. Dispenser for patient infusion device
US20050203461A1 (en) 2002-04-23 2005-09-15 Insulet Corporation Transcutaneous fluid delivery system
US6960192B1 (en) 2002-04-23 2005-11-01 Insulet Corporation Transcutaneous fluid delivery system
US6656159B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US20050238507A1 (en) 2002-04-23 2005-10-27 Insulet Corporation Fluid delivery device
US6723072B2 (en) 2002-06-06 2004-04-20 Insulet Corporation Plunger assembly for patient infusion device
US7104972B2 (en) 2002-07-10 2006-09-12 Novo Nordisk A/S Injection device with a dose setting limiter
US6945961B2 (en) 2002-07-10 2005-09-20 Novo Nordisk A/S Injection device
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US20060041229A1 (en) 2002-07-16 2006-02-23 Insulet Corporation Flow restriction system and method for patient infusion device
US7018360B2 (en) 2002-07-16 2006-03-28 Insulet Corporation Flow restriction system and method for patient infusion device
US7133329B2 (en) 2002-07-23 2006-11-07 Novo Nordisk A/S Device with time indicating means
US20050192561A1 (en) 2002-07-24 2005-09-01 M 2 Medical A/S Infusion pump system, an infusion pump unit and an infusion pump
US7232423B2 (en) 2002-07-24 2007-06-19 M2 Medical A/S Infusion pump system, an infusion pump unit and an infusion pump
US20050160858A1 (en) 2002-07-24 2005-07-28 M 2 Medical A/S Shape memory alloy actuator
US20040019325A1 (en) 2002-07-29 2004-01-29 Medrip Ltd. Syringe Pump
DE10236669A1 (en) 2002-08-09 2004-02-19 Korszak, Dieter Pen for administration of insulin injections, comprising LED to display amount to be injected, acoustic repeat and timer to give visual and acoustic indications of dosages and timings
US6948918B2 (en) 2002-09-27 2005-09-27 Novo Nordisk A/S Membrane pump with stretchable pump membrane
US20040064096A1 (en) 2002-09-30 2004-04-01 Flaherty J. Christopher Components and methods for patient infusion device
US20040064088A1 (en) 2002-09-30 2004-04-01 William Gorman Dispenser components and methods for patient infusion device
US7128727B2 (en) 2002-09-30 2006-10-31 Flaherty J Christopher Components and methods for patient infusion device
US7014625B2 (en) 2002-10-07 2006-03-21 Novo Nordick A/S Needle insertion device
US6690192B1 (en) 2002-10-16 2004-02-10 Pericom Semiconductor Corp. Current-compensated CMOS output buffer adjusting edge rate for process, temperature, and Vcc variations
US20050245878A1 (en) 2002-11-05 2005-11-03 M 2 Medical A/S Disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US20040116866A1 (en) 2002-12-17 2004-06-17 William Gorman Skin attachment apparatus and method for patient infusion device
US20050251097A1 (en) 2002-12-23 2005-11-10 M 2 Medical A/S Flexible piston rod
US20050273059A1 (en) 2002-12-23 2005-12-08 M 2 Medical A/S Disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US20040171983A1 (en) 2003-02-24 2004-09-02 Integrated Sensing Systems, Inc. Fluid delivery system and sensing unit therefor
US20060069382A1 (en) 2003-04-11 2006-03-30 Novo Nordisk A/S Delivery device
US20050182366A1 (en) 2003-04-18 2005-08-18 Insulet Corporation Method For Visual Output Verification
US20050022274A1 (en) 2003-04-18 2005-01-27 Robert Campbell User interface for infusion pump remote controller and method of using the same
US20050090808A1 (en) 2003-04-30 2005-04-28 Luis Malave Multi-processor medical device
US20040220551A1 (en) 2003-04-30 2004-11-04 Flaherty J. Christopher Low profile components for patient infusion device
US20060074381A1 (en) 2003-04-30 2006-04-06 Luis Malave Medical device initialization method & system
US20050222645A1 (en) 2003-04-30 2005-10-06 Luis Malave Microchip-based medical device
US20050215982A1 (en) 2003-04-30 2005-09-29 Luis Malave RF medical device
US20060095014A1 (en) 2003-05-08 2006-05-04 Novo Nordisk A/S External inserter for transcutaneous device
US20060135913A1 (en) 2003-05-08 2006-06-22 Novo Nordisk A/S Pivotable needle unit
US20060142698A1 (en) 2003-05-08 2006-06-29 Novo Nordisk A/S Internal needle inserter
US20060184119A1 (en) 2003-06-17 2006-08-17 Axel Remde Modular infusion pump
EP1495775A1 (en) 2003-07-08 2005-01-12 Novo Nordisk A/S Portable drug delivery device having an encapsulated needle
US20060200073A1 (en) 2003-07-08 2006-09-07 Novo Nordisk A/S Portable drug delivery device having an encapsulated needle
US6899695B2 (en) 2003-08-08 2005-05-31 Hector J. Herrera Medication security apparatus and method
US20060247581A1 (en) 2003-09-08 2006-11-02 Novo Nordisk A/S Threaded rod and nut assembly
US20050065760A1 (en) 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
CA2543545A1 (en) 2003-10-21 2005-05-06 Ole Christian Nielsen Medical injection device mountable to the skin
EP1527792A1 (en) 2003-10-27 2005-05-04 Novo Nordisk A/S Medical injection device mountable to the skin
US20050095063A1 (en) 2003-10-30 2005-05-05 Fathallah Marwan A. Medical device system
US20050267402A1 (en) 2004-05-27 2005-12-01 Janice Stewart Multi-state alarm system for a medical pump
US20060178633A1 (en) 2005-02-03 2006-08-10 Insulet Corporation Chassis for fluid delivery device
US20080208627A1 (en) 2005-03-17 2008-08-28 Ole Skyggebjerg Securing Pairing of Electronic Devices
EP1754498A1 (en) 2005-08-19 2007-02-21 Roche Diagnostics GmbH Driving device for an injection or infusion device
US20070073228A1 (en) 2005-09-26 2007-03-29 Morten Mernoe Dispensing fluid from an infusion pump system
US20070156092A1 (en) 2005-09-26 2007-07-05 M2 Medical A/S Operating an Infusion Pump System
US20070167905A1 (en) 2005-09-26 2007-07-19 M2 Medical A/S Operating an Infusion Pump System
US20070167912A1 (en) 2005-09-26 2007-07-19 M2 Medical A/S Operating an Infusion Pump System
US20070073236A1 (en) 2005-09-26 2007-03-29 Morten Mernoe Dispensing fluid from an infusion pump system
US20070124002A1 (en) 2005-11-08 2007-05-31 M2 Medical A/S Method and System for Manual and Autonomous Control of an Infusion Pump

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Accu-Chek Spirit, "Pump Therapy Made for You," Roche, 2006, 6 pages.
Debiotech News Release, "Debiotech reveals its new miniaturized Disposable Insulin Nanopump(TM) for Diabetes therapy," available at http://www.debiotech.com/news/nw-159.html Apr. 24, 2006, 3 pages.
Debiotech News Release, "Debiotech reveals its new miniaturized Disposable Insulin Nanopump™ for Diabetes therapy," available at http://www.debiotech.com/news/nw—159.html Apr. 24, 2006, 3 pages.
Medtronic News Release, "Medtronic Receives FDA Approval for World's First Insulin Pump with Real-time Continuous Glucose Monitoring," Apr. 13, 2006, 3 pages.
OmniPod Insulin Management System-Investor Relations-Press Release, Feb. 1, 2005, http://investors.insulet.com/phoenix.zhtml?c=209336&p=irol-newsArticle&ID=988708&highlight= 1 page.
OmniPod Insulin Management System—Investor Relations—Press Release, Feb. 1, 2005, http://investors.insulet.com/phoenix.zhtml?c=209336&p=irol-newsArticle&ID=988708&highlight= 1 page.
OmniPod Quick Start Guide, 2007, 2 pages.
Patent Abstracts of Japan, vol. 1999, No. 04, and JP 11 010036 , Apr. 30, 1999 and Jan. 19, 1999, Toray Ind. Inc.
The Medtronic Diabetes Connection, 2006, 6 pages.
U.S. Appl. No. 11/362,616.
Xilas Temp Touch, "The latest in high-tech and convenient devices," DOCNews, vol. 2, No. 7, Jul. 1, 2005, http://docnews.diabetesjournals.ord/cgi/content/full/2/7/13, 3 pages.

Cited By (319)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080021436A1 (en) * 1998-04-30 2008-01-24 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US20090163789A1 (en) * 1998-04-30 2009-06-25 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20090192370A1 (en) * 1998-04-30 2009-07-30 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) * 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100094110A1 (en) * 1998-04-30 2010-04-15 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346399B2 (en) * 2002-02-28 2013-01-01 Tandem Diabetes Care, Inc. Programmable insulin pump
US20050143864A1 (en) * 2002-02-28 2005-06-30 Blomquist Michael L. Programmable insulin pump
US10049768B2 (en) 2002-02-28 2018-08-14 Tandem Diabetes Care, Inc. Programmable insulin pump
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8512246B2 (en) 2003-04-28 2013-08-20 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US20070203872A1 (en) * 2003-11-28 2007-08-30 Manyworlds, Inc. Affinity Propagation in Adaptive Network-Based Systems
US9750440B2 (en) 2005-05-17 2017-09-05 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8653977B2 (en) 2005-05-17 2014-02-18 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US10206611B2 (en) 2005-05-17 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US9332944B2 (en) 2005-05-17 2016-05-10 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US9649439B2 (en) 2005-08-31 2017-05-16 Michael Sasha John Systems and methods for facilitating patient-based adjustment of drug infusion
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US8638220B2 (en) 2005-10-31 2014-01-28 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US10307091B2 (en) 2005-12-28 2019-06-04 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9326727B2 (en) 2006-01-30 2016-05-03 Abbott Diabetes Care Inc. On-body medical device securement
US10448834B2 (en) 2006-02-28 2019-10-22 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US9844329B2 (en) 2006-02-28 2017-12-19 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US9782076B2 (en) 2006-02-28 2017-10-10 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US9031630B2 (en) 2006-02-28 2015-05-12 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US11806110B2 (en) 2006-08-07 2023-11-07 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US11445910B2 (en) 2006-08-07 2022-09-20 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US9697332B2 (en) 2006-08-07 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US10206629B2 (en) 2006-08-07 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US9408566B2 (en) 2006-08-09 2016-08-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9833181B2 (en) 2006-08-09 2017-12-05 Abbot Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US11864894B2 (en) 2006-08-09 2024-01-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US10278630B2 (en) 2006-08-09 2019-05-07 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9357959B2 (en) 2006-10-02 2016-06-07 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9629578B2 (en) 2006-10-02 2017-04-25 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US10342469B2 (en) 2006-10-02 2019-07-09 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9839383B2 (en) 2006-10-02 2017-12-12 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8753316B2 (en) 2006-10-17 2014-06-17 Tandem Diabetes Care, Inc. Insulin pump for determining carbohydrate consumption
US8998878B2 (en) 2006-10-17 2015-04-07 Tandem Diabetes Care, Inc. Insulin pump having correction factors
US8961465B2 (en) 2006-10-17 2015-02-24 Tanden Diabetes Care, Inc. Insulin pump having a food database
US11217339B2 (en) 2006-10-17 2022-01-04 Tandem Diabetes Care, Inc. Food database for insulin pump
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US11837358B2 (en) 2006-10-31 2023-12-05 Abbott Diabetes Care Inc. Infusion devices and methods
US10007759B2 (en) 2006-10-31 2018-06-26 Abbott Diabetes Care Inc. Infusion devices and methods
US11508476B2 (en) 2006-10-31 2022-11-22 Abbott Diabetes Care, Inc. Infusion devices and methods
US11043300B2 (en) 2006-10-31 2021-06-22 Abbott Diabetes Care Inc. Infusion devices and methods
US9064107B2 (en) 2006-10-31 2015-06-23 Abbott Diabetes Care Inc. Infusion devices and methods
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
US10349877B2 (en) 2007-04-14 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10111608B2 (en) 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US11039767B2 (en) 2007-04-14 2021-06-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9737249B2 (en) 2007-05-14 2017-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9060719B2 (en) 2007-05-14 2015-06-23 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11300561B2 (en) 2007-05-14 2022-04-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US11828748B2 (en) 2007-05-14 2023-11-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10976304B2 (en) 2007-05-14 2021-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9558325B2 (en) 2007-05-14 2017-01-31 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10045720B2 (en) 2007-05-14 2018-08-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10463310B2 (en) 2007-05-14 2019-11-05 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11076785B2 (en) 2007-05-14 2021-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9483608B2 (en) 2007-05-14 2016-11-01 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8612163B2 (en) 2007-05-14 2013-12-17 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11119090B2 (en) 2007-05-14 2021-09-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10261069B2 (en) 2007-05-14 2019-04-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10820841B2 (en) 2007-05-14 2020-11-03 Abbot Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10119956B2 (en) 2007-05-14 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11125592B2 (en) 2007-05-14 2021-09-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8571808B2 (en) 2007-05-14 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10991456B2 (en) 2007-05-14 2021-04-27 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9797880B2 (en) 2007-05-14 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9804150B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8682615B2 (en) 2007-05-14 2014-03-25 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9801571B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10653344B2 (en) 2007-05-14 2020-05-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10143409B2 (en) 2007-05-14 2018-12-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10634662B2 (en) 2007-05-14 2020-04-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11257580B2 (en) 2007-05-24 2022-02-22 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US10943687B2 (en) 2007-05-24 2021-03-09 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US9474856B2 (en) 2007-05-24 2016-10-25 Tandem Diabetes Care, Inc. Expert system for infusion pump therapy
US11848089B2 (en) 2007-05-24 2023-12-19 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US10357607B2 (en) 2007-05-24 2019-07-23 Tandem Diabetes Care, Inc. Correction factor testing using frequent blood glucose input
US20120265722A1 (en) * 2007-05-24 2012-10-18 Michael Blomquist Expert system for insulin pump therapy
US9008803B2 (en) * 2007-05-24 2015-04-14 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11576594B2 (en) 2007-05-30 2023-02-14 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11298053B2 (en) 2007-05-30 2022-04-12 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11678821B2 (en) 2007-06-29 2023-06-20 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US9913600B2 (en) 2007-06-29 2018-03-13 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US10856785B2 (en) 2007-06-29 2020-12-08 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US9398872B2 (en) 2007-07-31 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US9804148B2 (en) 2007-10-23 2017-10-31 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US10173007B2 (en) 2007-10-23 2019-01-08 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US11083843B2 (en) 2007-10-23 2021-08-10 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US9743865B2 (en) 2007-10-23 2017-08-29 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US9332934B2 (en) 2007-10-23 2016-05-10 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US9439586B2 (en) 2007-10-23 2016-09-13 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US10685749B2 (en) 2007-12-19 2020-06-16 Abbott Diabetes Care Inc. Insulin delivery apparatuses capable of bluetooth data transmission
US10052049B2 (en) 2008-01-07 2018-08-21 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
US8718949B2 (en) 2008-01-07 2014-05-06 Tandem Diabetes Care, Inc. Insulin pump with blood glucose modules
US11302433B2 (en) 2008-01-07 2022-04-12 Tandem Diabetes Care, Inc. Diabetes therapy coaching
US9889250B2 (en) 2008-01-09 2018-02-13 Tandem Diabetes Care, Inc. Infusion pump with temperature monitoring
US8840582B2 (en) 2008-01-09 2014-09-23 Tandem Diabetes Care, Inc. Infusion pump with activity monitoring
US11850394B2 (en) 2008-01-09 2023-12-26 Tandem Diabetes Care, Inc. Infusion pump with add-on modules
US10773015B2 (en) 2008-01-09 2020-09-15 Tandem Diabetes Care, Inc. Infusion pump incorporating information from personal information manager devices
US9320468B2 (en) 2008-01-31 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9770211B2 (en) 2008-01-31 2017-09-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US11779248B2 (en) 2008-03-28 2023-10-10 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9730623B2 (en) 2008-03-28 2017-08-15 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9541556B2 (en) 2008-05-30 2017-01-10 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9795328B2 (en) 2008-05-30 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US10327682B2 (en) 2008-05-30 2019-06-25 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US11735295B2 (en) 2008-05-30 2023-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9931075B2 (en) 2008-05-30 2018-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US11621073B2 (en) 2008-07-14 2023-04-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US10328201B2 (en) 2008-07-14 2019-06-25 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US10188794B2 (en) 2008-08-31 2019-01-29 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US9610046B2 (en) 2008-08-31 2017-04-04 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US9572934B2 (en) 2008-08-31 2017-02-21 Abbott DiabetesCare Inc. Robust closed loop control and methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US11679200B2 (en) 2008-08-31 2023-06-20 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8795252B2 (en) 2008-08-31 2014-08-05 Abbott Diabetes Care Inc. Robust closed loop control and methods
US10045739B2 (en) 2008-09-30 2018-08-14 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US10009244B2 (en) 2009-04-15 2018-06-26 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US10820842B2 (en) 2009-04-29 2020-11-03 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US11013431B2 (en) 2009-04-29 2021-05-25 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US11298056B2 (en) 2009-04-29 2022-04-12 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US11116431B1 (en) 2009-04-29 2021-09-14 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US10952653B2 (en) 2009-04-29 2021-03-23 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US10194844B2 (en) 2009-04-29 2019-02-05 Abbott Diabetes Care Inc. Methods and systems for early signal attenuation detection and processing
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US10872102B2 (en) 2009-07-23 2020-12-22 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US10827954B2 (en) 2009-07-23 2020-11-10 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11285263B2 (en) 2009-07-30 2022-03-29 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US10434253B2 (en) 2009-07-30 2019-10-08 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11135362B2 (en) 2009-07-30 2021-10-05 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US9936910B2 (en) 2009-07-31 2018-04-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US11234625B2 (en) 2009-07-31 2022-02-01 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US10660554B2 (en) 2009-07-31 2020-05-26 Abbott Diabetes Care Inc. Methods and devices for analyte monitoring calibration
US8718965B2 (en) 2009-07-31 2014-05-06 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US10881355B2 (en) 2009-08-31 2021-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US9814416B2 (en) 2009-08-31 2017-11-14 Abbott Diabetes Care Inc. Displays for a medical device
US11730429B2 (en) 2009-08-31 2023-08-22 Abbott Diabetes Care Inc. Displays for a medical device
US10123752B2 (en) 2009-08-31 2018-11-13 Abbott Diabetes Care Inc. Displays for a medical device
US11241175B2 (en) 2009-08-31 2022-02-08 Abbott Diabetes Care Inc. Displays for a medical device
US11202586B2 (en) 2009-08-31 2021-12-21 Abbott Diabetes Care Inc. Displays for a medical device
USRE47315E1 (en) 2009-08-31 2019-03-26 Abbott Diabetes Care Inc. Displays for a medical device
US10456091B2 (en) 2009-08-31 2019-10-29 Abbott Diabetes Care Inc. Displays for a medical device
US10918342B1 (en) 2009-08-31 2021-02-16 Abbott Diabetes Care Inc. Displays for a medical device
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US11090432B2 (en) 2009-12-04 2021-08-17 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US11164672B2 (en) 2010-01-22 2021-11-02 Deka Products Limited Partnership System and apparatus for electronic patient care
US11810653B2 (en) 2010-01-22 2023-11-07 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US10872685B2 (en) 2010-01-22 2020-12-22 Deka Products Limited Partnership Electronic patient monitoring system
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US10242159B2 (en) 2010-01-22 2019-03-26 Deka Products Limited Partnership System and apparatus for electronic patient care
US11524107B2 (en) 2010-01-22 2022-12-13 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11424029B2 (en) 2010-01-22 2022-08-23 Deka Products Limited Partnership System, method and apparatus for electronic patient care
US10391241B2 (en) 2010-01-22 2019-08-27 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11776671B2 (en) 2010-01-22 2023-10-03 Deka Products Limited Partnership Electronic patient monitoring system
US8894631B2 (en) 2010-03-24 2014-11-25 Baxter International Inc. Multiple drug infusion system and method
US20110238032A1 (en) * 2010-03-24 2011-09-29 Baxter International Inc. Multiple drug infusion system and method
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11627898B2 (en) 2011-02-28 2023-04-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11534089B2 (en) 2011-02-28 2022-12-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8333717B1 (en) 2011-06-21 2012-12-18 Yofimeter, Llc Test unit cartridge for analyte testing device
US8333716B1 (en) 2011-06-21 2012-12-18 Yofimeter, Llc Methods for using an analyte testing device
US8961432B2 (en) 2011-06-21 2015-02-24 Yofimeter, Llc Analyte testing devices
US11484644B2 (en) 2011-09-13 2022-11-01 Unl Holdings Llc Sterile fluid pathway connection to drug containers for drug delivery pumps
US9721063B2 (en) 2011-11-23 2017-08-01 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US11783941B2 (en) 2011-11-23 2023-10-10 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US11205511B2 (en) 2011-11-23 2021-12-21 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US10136847B2 (en) 2011-11-23 2018-11-27 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9743872B2 (en) 2011-11-23 2017-08-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10939859B2 (en) 2011-11-23 2021-03-09 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9289179B2 (en) 2011-11-23 2016-03-22 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10082493B2 (en) 2011-11-25 2018-09-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US11391723B2 (en) 2011-11-25 2022-07-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US10316834B2 (en) 2011-12-21 2019-06-11 Deka Products Limited Partnership Peristaltic pump
US10753353B2 (en) 2011-12-21 2020-08-25 Deka Products Limited Partnership Peristaltic pump
US11210611B2 (en) 2011-12-21 2021-12-28 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11756662B2 (en) 2011-12-21 2023-09-12 Deka Products Limited Partnership Peristaltic pump
US9295778B2 (en) 2011-12-21 2016-03-29 Deka Products Limited Partnership Syringe pump
US11217340B2 (en) 2011-12-21 2022-01-04 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US10202971B2 (en) 2011-12-21 2019-02-12 Deka Products Limited Partnership Peristaltic pump
US9677555B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US11129933B2 (en) 2011-12-21 2021-09-28 Deka Products Limited Partnership Syringe pump, and related method and system
US10202970B2 (en) 2011-12-21 2019-02-12 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US10245374B2 (en) 2011-12-21 2019-04-02 Deka Products Limited Partnership Syringe pump
US11615886B2 (en) 2011-12-21 2023-03-28 Deka Products Limited Partnership Syringe pump and related method
US10288057B2 (en) 2011-12-21 2019-05-14 Deka Products Limited Partnership Peristaltic pump
US11826543B2 (en) 2011-12-21 2023-11-28 Deka Products Limited Partneship Syringe pump, and related method and system
US11295846B2 (en) 2011-12-21 2022-04-05 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US10857293B2 (en) 2011-12-21 2020-12-08 Deka Products Limited Partnership Apparatus for infusing fluid
US11511038B2 (en) 2011-12-21 2022-11-29 Deka Products Limited Partnership Apparatus for infusing fluid
US9789247B2 (en) 2011-12-21 2017-10-17 Deka Products Limited Partnership Syringe pump, and related method and system
US9744300B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Syringe pump and related method
US9675756B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership Apparatus for infusing fluid
US11705233B2 (en) 2011-12-21 2023-07-18 Deka Products Limited Partnership Peristaltic pump
US11348674B2 (en) 2011-12-21 2022-05-31 Deka Products Limited Partnership Peristaltic pump
US10561787B2 (en) 2011-12-21 2020-02-18 Deka Products Limited Partnership Syringe pump and related method
US11024409B2 (en) 2011-12-21 2021-06-01 Deka Products Limited Partnership Peristaltic pump
US10722645B2 (en) 2011-12-21 2020-07-28 Deka Products Limited Partnership Syringe pump, and related method and system
US11373747B2 (en) 2011-12-21 2022-06-28 Deka Products Limited Partnership Peristaltic pump
US11664106B2 (en) 2011-12-21 2023-05-30 Deka Products Limited Partnership Syringe pump
US11779703B2 (en) 2011-12-21 2023-10-10 Deka Products Limited Partnership Apparatus for infusing fluid
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US11881307B2 (en) 2012-05-24 2024-01-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US10911515B2 (en) 2012-05-24 2021-02-02 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11676694B2 (en) 2012-06-07 2023-06-13 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US10653834B2 (en) 2012-06-07 2020-05-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US10345291B2 (en) 2012-08-30 2019-07-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10942164B2 (en) 2012-08-30 2021-03-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10656139B2 (en) 2012-08-30 2020-05-19 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US11607492B2 (en) 2013-03-13 2023-03-21 Tandem Diabetes Care, Inc. System and method for integration and display of data of insulin pumps and continuous glucose monitoring
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US11357911B2 (en) 2013-10-24 2022-06-14 Trustees Of Boston University Infusion pump and system for preventing mischanneling of multiple medicaments
US10881789B2 (en) 2013-10-24 2021-01-05 Trustees Of Boston University Infusion system for preventing mischanneling of multiple medicaments
US10918785B2 (en) 2013-12-26 2021-02-16 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US11911590B2 (en) 2013-12-26 2024-02-27 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US10478551B2 (en) 2013-12-26 2019-11-19 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9737656B2 (en) 2013-12-26 2017-08-22 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US11383027B2 (en) 2013-12-26 2022-07-12 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9669160B2 (en) 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
US11672903B2 (en) 2014-09-18 2023-06-13 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US10265463B2 (en) 2014-09-18 2019-04-23 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US11331463B2 (en) 2015-07-08 2022-05-17 Trustees Of Boston University Infusion system and components thereof
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
EP3383456A4 (en) * 2015-12-03 2019-08-21 UNL Holdings LLC Systems and methods for controlled drug delivery pumps
EP3832661A1 (en) * 2015-12-03 2021-06-09 UNL Holdings LLC Systems and methods for controlled drug delivery pumps
US11638781B2 (en) 2015-12-29 2023-05-02 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10857287B2 (en) 2017-01-06 2020-12-08 Trustees Of Boston University Infusion system and components thereof
US11771821B2 (en) 2017-01-06 2023-10-03 Trustees Of Boston University Infusion system and components thereof
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11872368B2 (en) 2018-04-10 2024-01-16 Tandem Diabetes Care, Inc. System and method for inductively charging a medical device
US20190341137A1 (en) * 2018-05-07 2019-11-07 Medtronic Minimed, Inc. Proactive image-based infusion device delivery adjustments
US11367528B2 (en) 2018-05-07 2022-06-21 Medtronic Minimed, Inc. Proactive image-based infusion device delivery adjustments
US10861603B2 (en) * 2018-05-07 2020-12-08 Medtronic Minimed, Inc. Proactive image-based infusion device delivery adjustments
US11707615B2 (en) 2018-08-16 2023-07-25 Deka Products Limited Partnership Medical pump
US10967119B1 (en) 2019-04-01 2021-04-06 Azizi Bilal Wearable medication injecting device
US11633535B2 (en) 2019-07-16 2023-04-25 Beta Bionics, Inc. Ambulatory device and components thereof
US11571507B2 (en) 2019-07-16 2023-02-07 Beta Bionics, Inc. Ambulatory device and components thereof
US11135363B2 (en) 2019-07-16 2021-10-05 Beta Bionics, Inc. Ambulatory medicament device alarm system
US11135366B2 (en) 2019-07-16 2021-10-05 Beta Bionics, Inc. Ambulatory medical device with malfunction alert prioritization
US11135364B2 (en) 2019-07-16 2021-10-05 Beta Bionics, Inc. Ambulatory medicament device with alarm status indication
US11803367B2 (en) 2019-07-16 2023-10-31 Beta Bionics, Inc. Ambulatory medicament device with alarm
US11941392B2 (en) 2019-07-16 2024-03-26 Beta Bionics, Inc. Ambulatory medical device with malfunction alert prioritization
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
USD980859S1 (en) 2020-03-10 2023-03-14 Beta Bionics, Inc. Display screen with transitional graphical user interface
US11497849B2 (en) 2020-12-07 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11534546B2 (en) 2020-12-07 2022-12-27 Beta Bionics, Inc. Ambulatory medicament device with motion detection and gesture-based control
US11565041B2 (en) 2020-12-07 2023-01-31 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode

Also Published As

Publication number Publication date
EP1955240B8 (en) 2016-03-30
US9114209B2 (en) 2015-08-25
US20070124002A1 (en) 2007-05-31
EP1955240B1 (en) 2016-01-27
EP3064236B1 (en) 2020-02-05
US9205192B2 (en) 2015-12-08
EP3064236A1 (en) 2016-09-07
US20120220940A1 (en) 2012-08-30
WO2007056592A2 (en) 2007-05-18
US20120245524A1 (en) 2012-09-27
WO2007056592A3 (en) 2007-11-29
US20120245523A1 (en) 2012-09-27
EP1955240A2 (en) 2008-08-13
US20120245522A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
US8192394B2 (en) Method and system for manual and autonomous control of an infusion pump
JP6882383B2 (en) Insulin management
US11929158B2 (en) User interface for diabetes management system
JP6539290B2 (en) Insulin management
US6827702B2 (en) Safety limits for closed-loop infusion pump control
CA2471007C (en) Medication delivery system and monitor
CN114053517A (en) Operating a multi-mode drug delivery system
US20080234663A1 (en) Method for Selecting Bolus Doses in a Drug Delivery System
EP1436023B1 (en) Safety limits for closed-loop infusion pump control
RU2661715C2 (en) Method for determining value of acceptable increase in blood glucose level after food intake
US20240079111A1 (en) System and method for adjusting insulin delivery to account for insulin resistance
Bain The Cellnovo insulin delivery system
US20240075208A1 (en) Method for detecting occlusions in a fluid path using blood glucose readings
EP3723696A1 (en) User interface for diabetes management systems and devices
EP3724887A1 (en) Devices, systems, and methods for estimating active medication from injections

Legal Events

Date Code Title Description
AS Assignment

Owner name: M2 MEDICAL A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ESTES, MARK C.;WENGER, MITCHELL;MERNOE, MORTEN;AND OTHERS;SIGNING DATES FROM 20070202 TO 20070208;REEL/FRAME:018889/0197

Owner name: M2 MEDICAL A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ESTES, MARK C.;WENGER, MITCHELL;MERNOE, MORTEN;AND OTHERS;REEL/FRAME:018889/0197;SIGNING DATES FROM 20070202 TO 20070208

AS Assignment

Owner name: M2 MEDICAL GROUP HOLDINGS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:022440/0904

Effective date: 20090324

Owner name: M2 MEDICAL GROUP HOLDINGS, INC.,CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:022440/0904

Effective date: 20090324

AS Assignment

Owner name: M2 GROUP HOLDINGS, INC., CALIFORNIA

Free format text: CORRECTIVE DOCUMENT ORIGINAL DOCUMENT WAS RECORDED AT REEL 022440, FRAME 0904.;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:022619/0510

Effective date: 20090324

Owner name: M2 GROUP HOLDINGS, INC.,CALIFORNIA

Free format text: CORRECTIVE DOCUMENT ORIGINAL DOCUMENT WAS RECORDED AT REEL 022440, FRAME 0904;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:022619/0510

Effective date: 20090324

Owner name: M2 GROUP HOLDINGS, INC., CALIFORNIA

Free format text: CORRECTIVE DOCUMENT ORIGINAL DOCUMENT WAS RECORDED AT REEL 022440, FRAME 0904;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:022619/0510

Effective date: 20090324

AS Assignment

Owner name: ASANTE SOLUTIONS, INC.,CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:M2 GROUP HOLDINGS, INC.;REEL/FRAME:024505/0516

Effective date: 20100406

Owner name: ASANTE SOLUTIONS, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:M2 GROUP HOLDINGS, INC.;REEL/FRAME:024505/0516

Effective date: 20100406

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: BIGFOOT BIOMEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASANTE LLC;REEL/FRAME:036047/0389

Effective date: 20150527

Owner name: ASANTE LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASANTE SOLUTIONS, INC.;REEL/FRAME:036049/0175

Effective date: 20150522

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8

AS Assignment

Owner name: MADRYN HEALTH PARTNERS, LP, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:BIGFOOT BIOMEDICAL, INC.;REEL/FRAME:055583/0044

Effective date: 20210312

AS Assignment

Owner name: MADRYN FUND ADMINISTRATION, LLC, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:MADRYN HEALTH PARTNERS, LP;REEL/FRAME:062702/0145

Effective date: 20230209

AS Assignment

Owner name: BIGFOOT BIOMEDICAL, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MADRYN FUND ADMINISTRATION, LLC;REEL/FRAME:062793/0316

Effective date: 20230209

AS Assignment

Owner name: INSULET CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIGFOOT BIOMEDICAL, INC.;REEL/FRAME:063909/0826

Effective date: 20230209

AS Assignment

Owner name: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT, MARYLAND

Free format text: SECURITY AGREEMENT SUPPLEMENT;ASSIGNOR:INSULET CORPORATION;REEL/FRAME:064840/0181

Effective date: 20230609

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12